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Abstract
Using moderate dosages and human subjects having prior 
recreational experience with marijuana, highly significant 
changes in a system of cardiovascular and psychological vari­
ables were observed in subjects who smoked marijuana contain­
ing A XTHC, but not for control subjects who smoked placebo 
marijuana. The major hypothesis that marijuana produces a 
specific cardiovascular pattern suggestive of mild, tran­
sient, cerebral ischemia was supported by the data. The ob­
servation of cerebral and peripheral vasoconstriction with no 
change in systolic and diastolic blood pressure is indicative 
of decreased perfusion in higher CNS and peripheral struc­
tures, despite the significant tachycardia which appears to 
be an unsuccessful homeostatic compensatory mechanism.
Concomitant changes in psychological functioning were 
found following ingestion of marijuana containing A^HC. The 
gross overestimation of a two-minute interval by intoxicated 
subjects was interpreted in accordance with theoretical work 
relating change in heart rate to acceptance or rejection of 
environmental cues. These subjects also made significantly 
more errors on a short-term visual recall task than the con­
trol group. Errors of the former group were most frequently 
major perseverations and confabulations, while those of the 
latter group were relatively minor. Neither a disjunctive 
reaction-time task nor a standard measure of situational 
anxiety appeared to be sensitive discriminators of the 
marijuana-intoxicated state, although subjective ratings of
viii
intoxication level corresponded closely with dosage. Some 
neuropsychological and psychophysiological implications of 
this research were discussed.
Introduction
A. Introductory Remarks
The organization of the literature review in this chap­
ter is intended to provide some integration of several ap­
proaches (e.g. psychology, physiology, pharmacology) to the 
delineation of relevant questions concerning the effects of 
marijuana on the human organism. Brief comments concerning 
some historical and methodological difficulties of marijuana 
research will be followed by more extensive discussions of 
pharmacological issues (dosage and toxicity), physiological 
issues (metabolism), effects of long-term usage, and final­
ly, physiological and psychological changes during acute in­
toxication.
B. Brief History
The proliferation of scientific research on marijuana 
has largely been related to two periods of its increased so­
cial visibility during this century. By the 1930's mari­
juana smoking throughout the South (where the plant was grown 
for making rope), although not as widespread as it is today, 
was an issue of public concern. Most of the marijuana traf­
fic came through New Orleans on its way to the ghettos of New 
York City. The New Orleans Item (February 4, 5, 1924?
October 22, 1926) and the Morning Tribune (October 17, 19-23, 
28, 1926) assured New Orleaneans and the rest of the country 
that marijuana use was a widespread habit among the populace. 
A state official claimed it was directly responsible for the
2murders and other violent crimes of that city (Walton, 1938). 
The Eastern press and the Bureau of Narcotics soon followed 
suit. With the hurried passage of the Marijuana Tax Act of 
1937, the American Medical Association (which had previously 
favored the use of marijuana extracts in treating a wide va­
riety of symptoms) forever closed its house organ to research 
which did not agree with the views of the Bureau of Narcotics 
(Grinspoon, 1971, pp. 27-29, 329-331).
Amid this political activity, the "La Guardia Commission" 
(Mayor's Committee on Marijuana, 1944) began collecting psy­
chological, sociological, physiological and pharmacological 
data which would later appear in a 1944 monograph. This mono­
graph represented the first major contribution to scientific 
literature on cannabis sativa since the report of the Indian 
Hemp Drug Commission in 1894. Although a major attempt to de­
lineate physiological and behavioral changes associated with 
marijuana intoxication, the studies fostered by the La Guardia 
Commission (Adams, 1942; Allentuck, 1944; Halpern, 1944; 
Morrow, 1944; Wikler and Lloyd, 1945; Williams et al, 1946a, 
1946b) were carried out under adverse conditions. Subjects 
were prisoners with variable histories of single or multiple 
drug abuse and heterogenous backgrounds. More importantly, 
little was known about the chemistry of cannabis sativa at 
that time, and it was typically administered ad libitum by 
inhalation, oral ingestion or injection of an alcohol- 
saturated extract, with no control of amount of active sub­
stance.
3A second surge of scientific interest in marijuana began 
in the early 1960's concurrent with its introduction to the 
college campus. Grinspoon (1971), who has provided an excel­
lent historical account of marijuana usage in the United 
States, has assigned an important role to the returning ser­
viceman in introducing marijuana to an entirely new segment 
of society. Some of this recent research (e.g. Waskow and 
associates, 1970; Meyer and associates, 1971) is subject to 
the same adversities that have characterized the La Guardia 
studies, although two methodological advances have recently 
been made which alleviate some earlier shortcomings.
The first methodological problem to be overcome was that 
of assaying crude marijuana preparations varying widely as to 
content of psychoactive substances. Not until 1964 (Gaoni 
and Mechoulam) was the active component isolated and its struc­
ture roughly determined. Mechoulam (1970) provides an excel­
lent discussion of the chemical constituents of marijuana.
The major psychoactive substance in all marijuana is A1 tetra­
hydrocannabinol (THC; sometimes labelled as A9THC, depending 
on the numbering system used). Two acids, A1THC A and B, are 
also found in very small quantities in most preparations.
These are psychologically inactive per se, but when smoked, 
they are converted into the active A1THC. This is one of the 
reasons for the greater psychoactivity of smoked marijuana 
compared to ingestion. A third active minor component is a 
A1f61thc isomer which may constitute up to 10% of the com­
bined THC content of fresh marijuana. However, in a wide
variety of samples studied, the ratio of A*THC to Air6^THC 
varied from 99:1 to 99.1:0.1, suggesting that only A1THC 
need be considered in assays for most experimental purposes. 
The three major psychologically-inactive substances found in 
crude marijuana are cannabinol, cannabidiol and cannabigerol.
A*THC, upon exposure to air and/or heat, gradually deterio­
rates to the inactive cannabinol at the rate of 3% to 5% per 
month for material kept at room temperature (Lerner, 1969; 
Liskow, 1970). Cannabidiol and cannabigerol are antibiotic 
in vitro. Several properties of AlTHC should be noted in 
that they affect methodological problems in experimentation.
THC is a water insoluble, oily, resinous substance which 
can only be extracted from the crude material using petroleum 
ethers, usually ethyl alcohol, for purposes of oral and in­
travenous injections. Experimental results obtained with 
such a compound must be interpreted with caution, because of 
the confounding effects of alcohol.
The popularity of injectable and oral THC extracts, as 
well as synthetics (particularly synhexyl and pyrahexyl) has 
been in part a reflection of the difficulty in determining 
THC uptake when it is smoked. This has been an unfortunate 
limitation, since the course of behavioral and physiological 
action is very different for inhaled THC than for other forms 
of ingestion. When smoked, the onset of measured and reported 
physiological effects is quite rapid, usually occurring at 
maximum level in about 15 minutes and lasting from two to 
three hours (DeLong, 1972; Hollister, 1971). Intravenous and
5oral doses may not be measured or reported for an hour or 
more, post-administration, and may be effective for as long 
as six to eight hours (Allentuck, 1944). In addition, as 
much as two to three times the amount of THC in a cigarette 
must be delivered by injection or ingestion in order to pro­
duce equivalent effects (Isbell, Gerodetsky, Jasinski, 
Claussen, Spulak and Korte, 1967). Recent investigation 
(unsigned, 1971; Manno, Kiplinger, Haine, Bennett and Forney, 
1970) has determined that, under smoking conditions which are 
only roughly standardized, approximately 50% of the active 
THC component in a cigarette is actually delivered to the 
lungs of a smoker. Estimations made under various methods of 
burning marijuana cigarettes have shown the 50% estimate to 
be a robust assumption. Using this data, the delivered dos­
age of THC can easily be calculated in human studies, thus 
alleviating a second major methodological hindrance to natu­
ralistic investigations.
C. Dosage and Toxicity
Although minimal (threshold) and effective ("perceptu­
al") dosage ranges can be roughly specified for THC, there is 
a good deal of interindividual variability which is seemingly 
dependent on route of administration, past usage history and 
probably set and setting as well. Isbell and associates 
(1967) report the threshold dose for THC in injected form to 
be roughly three times (75 micrograms/kilogram) that of 
smoked THC. Grinspoon (1971, pp. 227-228) suggests a thresh­
old range between 25 and 50 micrograms/kilogram with smoked
6marijuana. The perceptual dosages, at which clearly distorted 
bodily sensations, visual illusions (usually consisting of 
distortions and/or confabulations of incoming auditory or vi­
sual stimuli, rather than true hallucinations) occur, are in 
the neighborhood of 100 micrograms/kilogram (kg.) for smoked 
THC and 240 micrograms/kg. for orally administered THC. For 
a human S of average weight (75 kg.) the threshold and per­
ceptual dosages of smoked THC would be approximately .025 
gram and .075 gram respectively.
The toxicity of marijuana (e.g. referring to its THC 
content) is an interesting topic in view of societal concerns 
about the drug. Jaffe (1970) and Weil (1970) , in reviewing 
the world literature, concluded that no death has ever been 
reported which was the result of marijuana intoxication alone. 
Grinspoon (1971, p. 228) discusses four cases of death in 
India which were purported to be the result of marijuana in­
toxication, but concludes that evidence for such a relation­
ship was either nonexistant or extremely circumstantial. The 
National Commission on Marijuana and Drug Abuse (1972, p. 73) 
reports a study of the effects of a very high daily dose 
(100,000 times the effective human dose) in rats and monkeys 
over a period of three months. There was initial, severe cen­
tral nervous system (CNS) depression in both species which re­
sulted in a few fatalities among rats but none among monkeys. 
After development of tolerance, all rats evidenced extreme hy­
peractivity. The monkeys initially showed mild hyperactivity, 
but returned to normal behavior after tolerance developed.
7The Commission concluded that the margin of safety between 
the active and toxic dose of THC was enormous. A study of 
Mikuriya (reported by Grinspoon, 1971) compared the toxicity 
of marijuana (based on an extrapolation of data on mice) to 
that of secobarbitol and alcohol in humans. With marijuana 
the ratio of toxic dose (of THC) to effective dose is some­
thing on the order of 40,000:1, whereas for secobarbitol it 
is 3-50:1 and for alcohol 4-10:1.
In a considerition of psychoactive drugs such as mari­
juana, toxicity is a concept which can also be applied to in­
stances of significant and/or irreparable psychological dam­
age to human subjects. It is this area that has been of most 
concern in investigations of marijuana effects, whether in 
the laboratory, in clinical practice or in survey projects. 
Cannabis sativa is certainly not a narcotic, although it has 
been misclassified as an hallucinogen. Real hallucinations, 
defined as perceptions which have no demonstrable basis in re­
ality, do not occur during cannabis intoxication (DeLong,
1972; Grinspoon, 1971; Hollister, 1971; Waskow, Olsson, Salzman 
and Katz, 1970). Perceptual distortions, however, have been 
reliably reported in instances where high dosages of THC were 
administered (Grinspoon, 1971; Hollister, 1971; Halikas,
Goodwin and Guse, 1971). These distortions typically take 
such forms as increases in apparent brightness of colors, time 
sense distortion, loose associations, and occasional intrusion 
of peripheral visual and auditory stimuli to which undue sig­
nificance or meaning is attached. Perceptual distortions
8usually occur within the pleasurable context of a "double­
consciousness" which has frequently been described as a major 
characteristic of marijuana intoxication (e.g. Grinspoon,
1971, pp. 133-135; Isbell et al, 1967). This state might be 
roughly described as the presence of an "observing ego" cap­
able of objective reality-testing and aware of the altered 
state of the rest of the personality (awareness of an altered 
state of awareness). Cannabis has little of the stimulant ef­
fects of LSD, and there is no cross tolerance between LSD and 
THC (Jaffe, 1970). Isbell and Jasinski (1969) compared the 
effects of smoked THC (dosages between 75 and 225 micrograms/ 
kg.) to LSD injections (0.5 to 1.5 micrograms/kg.), finding 
little difference in subjective effects. Physiological ef­
fects were markedly different, however. LSD elevated body 
temperature, increased systolic and diastolic blood pressure, 
exaggerated deep reflexes and dilated pupils. THC had none 
of these effects. THC has been found to prolong barbiturate 
sleeping time as well as amphetamine-induced excitation in 
mice (Garriot et al, 1967). It may be that marijuana should 
be classified as neither an hallucinogen nor hypnotic, but as 
a unique drug, as DeLong (1972) has suggested. Prior to 1937, 
marijuana was considered to be an analgesic. This may yet 
prove to be the most accurate classification.
A major factor in the occurrence, although infrequent, of 
"bad trips", unpleasant physical effects and adverse reactions 
(including panic states and psychotic breaks) is likely to be 
the contamination of marijuana. When the drug, particularly
9the Asian or South American variety, is obtained through il­
legal channels it is frequently diluted with other substances. 
Some of these substances are relatively innocuous, such as 
parsley, oregano and other common grasses. Others, however, 
are not; experienced users who are dealers or have close con­
tacts with that subculture report that marijuana is frequently 
mixed with amphetamines, LSD, cocaine, opium, or even heroin 
as a method of increasing the quality (and considerably en­
hancing the resale value) of otherwise low potency material. 
Some of the adverse reactions reported in clinical and survey 
studies are probably the result either of knowing or unknow­
ing multiple drug abuse. Smith (1968, p. 41) reports results 
from a 15-month study at the Haight-Asbury Clinic in San 
Francisco. During this period, approximately 30,000 indivi­
duals were treated for various medical and psychiatric prob­
lems. Although 95% had used marijuana, no case of a psychotic 
break was recorded. Talbott and Teague (1969) report 12 in­
cidents of marijuana-related psychotic breaks among soldiers 
stationed in Vietnam during a 10-month period. The composi­
tion of the ingested drug was unknown, and all 12 reactions 
developed from an initial use of marijuana. Even though two 
of the individuals had "significant psychiatric histories 
and diagnosis of personality disorder", all reactions were 
short-lived and cleared spontaneously. These authors esti­
mated that approximately 150,000 soldiers had used mari­
juana at least once during the 10-month time period and con­
cluded that the incidence of psychotic reaction related to
10
its use was very low. Chopra and Chopra (1939) in two well- 
controlled studies of 466 and 772 marijuana users found preva­
lence rates for psychosis of 1.93% and 0.52%, respectively. 
Freeman and Rochmore (1946a, 1946b) surveyed 310 soldiers who 
had used marijuana an average of 7.1 years, and found no his­
tory of psychosis. It seems probable that the incidence of 
psychotic breaks among marijuana users is no higher than that 
of the general population.
DeLong (1972) classifies adverse reactions to marijuana 
in four categories: (1) simple depression, (2) panic state,
(3) toxic psychosis, and (4) psychotic break. He reports 
that simple depression, probably resulting from the pharmaco­
logical effects of the drug, is the most common adverse reac­
tion, and that it invariably ends spontaneously. In discus­
sing the second category of reactions, Weil (1970) suggests 
that panic occurs when a user interprets the use or physiologi­
cal effects of marijuana as a threat to life or sanity. Us­
ers exhibiting panic reactions are usually trying marijuana 
for the first time. Such reactions may exemplify the theory 
of emotion developed by Schacter and Singer (1962) which sug­
gests that emotional quality is the product of physiological 
arousal and cognitive labelling or interpretation. More ex­
perienced users, or beginners more familiar with the culture 
surrounding marijuana usage, typically ascribe highly posi­
tive labels to the same set of physiological changes that may 
cause panic in the naive individual. The real danger in panic 
reactions is that they are frequently labelled as toxic
11
psychoses in the clinic, thereby leading to hospitalization 
and thd use of tranquilizers which typically intensify rather 
than alleviate the reaction (DeLong, 1972; Grinspoon, 1971). 
Explanation and reassurance is the treatment of choice in 
such cases.
D. Metabolism
Few, if any, clear findings are presently available as 
to what happens to THC once it enters the body. The most con­
sistently implicated organs have been the liver, brain and 
lungs. Dahi (1951) found a 30% decrease in glycogen synthe­
sis in the liver and a 50% reduction of anaerobic glycolysis 
in the brain after injecting rats with parahexyl (a synthetic 
compound thought to be similar in action to THC). Miras 
(1965, pp. 37-47) was able to label THC extract with radioac­
tive molecules. This substance was also injected in rats and 
its distribution studied when the animals were sacrificed one 
and one-half hours later. He found the largest concentration 
of the dose (5%) had been taken up in the liver. Only 2% of 
the injected dose was found in the brain. A probable reason 
for the small percentages of the original dose which Miras 
was able to detect is the two-phase biological half-life 
which seems to be characteristic of THC. This half-life is 
apparently longer in humans than other species. Augurell
(1970) has documented this with humans, again using carbon-14 
labelled tracer doses (5.6 to 7.9 micrograms/kg.) of THC 
which were injected intravenously. Using plasma samples, he 
found the initial, or rapid phase of degradation to last
12
about 30 minutes during which redistribution of the compound 
occurred. This was followed by a slow phase lasting approxi­
mately 50-60 hours. During the latter, unchanged THC concen­
tration gradually declined. Lemberger, Silberstein, Axelrod 
and Kopin (1970) have confirmed the finding of a two-phase 
half-life with marijuana-naive subjects. Lemberger, Tarnarkin, 
Axelrod and Kopin (1971), using intravenous injections of ra­
dioactive A*THC between five and eight micrograms/kg., found 
a second-phase half-life of 28 hours in chronic marijuana us­
ers (selected on the basis of having been daily users for one 
year), as compared to 57 hours for nonusers in the earlier 
study. Although the data do not lend substantial support to 
one interpretation rather than the other, Lemberger and as­
sociates (1971) conclude that the differences between heavy 
and nonuser groups may be the result of increased metabolism 
of A*THC (presumably through enzymatic activation) among 
heavy users rather than differences in tissue distribution. 
Enzymatic activation has been offered as one explanation of 
the "reverse tolerance" phenomenon among experienced users 
(Mechoulam, 1970). This concept refers to observations that 
marijuana-naive subjects rarely experience psychedelic effects 
during initial ingestions of the drug, and that heavy users 
can obtain the same degree of intoxication with smaller dos­
ages as that reported by less experienced users ingesting 
larger dosages (Grinspoon, 1971). However, A:THC has also 
been shown to bind with plasma lipoproteins to the extent of 
80 to 95% (Augurell, 1970); its relatively high volume of
13
distribution is typical of a drug which is bound in tissues; 
and it is a nonpolar compound likely to accumulate in fat or 
other tissues (particularly lung, liver, spleen and kidney) 
which have an affinity for such drugs (Lemberger and associ­
ates, 1970). The relatively small amounts of radioactive 
A1THC (or its metabolites) found in the brain and spinal cord 
is unusual. Although the human brain constitutes approximately 
2% of the total body weight, it receives about 20% of the 
total circulation. That A*THC is rapidly converted to vari­
ous metabolites and that the original substance and/or these 
derivatives combine extensively with lipoproteins outside the 
central nervous system (CNS) seem to be well-established find­
ings. Whether the "reverse-tolerance" phenomenon is the re­
sult of enzyme activation following initial ingestion of A1THC 
or a lowering of some kind of "intoxication threshold" when 
active metabolites are stored in tissue is, as yet, unclear.
The data on metabolism have, at present, provided no sugges­
tive evidence as to a mechanism of action.
Mclsaac, Fritchie, Indapaan-Meikkila, Ho and Englert
(1971) have studied the distribution of intravenously injected, 
radioactive, synthetic A1THC in the monkey brain. Dosages 
were two milligrams/kg. or 30 milligrams/kg. Some monkeys 
in each dosage group were sacrificed 15 minutes post-injection. 
Others were sacrificed at one hour, four hours and 24 hours. 
Brain sections were studied with autoradiography and thin- 
layer chromatography techniques. At 15 minutes post-injection, 
most of the radioactivity in the monkey brains was localized
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in neocortical structures, although with the higher dosage 
several subcortical structures (particularly the caudate nu­
cleus, hippocampus, thalamus, pons, and medulla) and the cere­
bellar cortex showed considerable radioactivity. With the 
longer time intervals between injection and study, radioactiv­
ity levels decreased markedly and were more evenly distrib­
uted throughout all brain structures. At nearly all of the 
intervals employed in the study, plasma was found to contain 
substantially more radioactive material than any other type 
of tissue. Least amounts of radioactive uptake were found in 
cortical white matter. Unfortunately, no data was provided 
by these authors concerning uptake in non-CNS organs which 
have previously been identified as the major target organs in 
investigations cited earlier. No estimate is therefore avail­
able as to percentage of total dose which was actually taken 
up in the CNS structures.
Both the response/time curve suggested by these data and 
the types of cortical structures most involved in low and high 
dosage groups relate well to anecdotal behavioral observations 
made by Mclsaac and associates. Behavioral aberrations seemed 
maximal about 15 minutes post-injection and were more severe 
with the higher dosage. With the lower dosage, the squirrel 
monkeys sat quietly, staring at the bottom of the cage. Nor­
mal aggressive responses, even to handling, were entirely ab­
sent, At a medium dose (10 milligrams/kg.), there was an ini­
tial period of excitation, random behavior, marked incoordi­
nation and "freezing" in awkward positions. At the highest
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dosage there was marked sedation and pronounced motor incoor­
dination.
E. Long-term Effects
DeLong (1972) has concluded that there is no reliable 
evidence of organic damage associated with marijuana use, al­
though heavy, long-term smokers may be liable to the same type 
of bronchial disorders associated with tobacco smoking. At 
present, there seems to be only two examples of long-term 
studies in the modern literature.
The first was published by Williams, Himmelsbach, Wikler 
and Ruble (1946) and was conducted at Lexington. This group 
studied six prisoners taking ad libitum doses (60 to 2,400 
milligrams, one to eight doses per day) of "pyrahexyl compound" 
from 26 to 31 days after a one-week observation period during 
which baseline measures were obtained. Initial behavioral ef­
fects of drowsiness, euphoria, dryness of the mouth, injected 
sclerae, increased appetite, spontaneous laughter, slowness 
of reaction and difficulty in expressing thoughts gave way, 
after two or three days, to a loss of interest in the environ­
ment, progressive lethargy, irritability and decreased abil­
ity to concentrate. Increasing the dosage brought only a tem­
porary return to the initial state. Physiological changes in­
cluded an initial acceleration and later slowing of pulse 
rate (but no change in blood pressure), lowering of rectal 
temperature, slowing of respiration, initial increase and la­
ter decrease in caloric intake, increase in body weight, and 
increased time sleeping. Although data on cognitive functioning
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are not reported, the authors report little change in achieve­
ment on psychological tests (Wechsler-Bellevue, Tapping speed, 
Minnesota mechanical ability test) given during the prelimi­
nary observations period, two weeks after beginning medica­
tion and on the third day after it was discontinued. Although 
little change was evident on Wechsler-Bellevue total scores, 
the authors concluded that the ability to focus attention be­
came increasingly difficult under medication. Rote memory 
seemed unaffected by the drug, and there was increased output, 
but a loss of accuracy on psychomotor tasks.
This paradigm was repeated by the same authors, with the 
exception that six prisoners (three from the initial study) 
were allowed to smoke marijuana ad libitum for a period of 39 
days. Marijuana was not assayed, and the only report as to 
the quantity consumed was in cigarettes per day (9-26). The 
results obtained with marijuana were generally similar to 
those with pyrahexyl. However, the initial euphoria and in­
crease in heart rate lasted for a longer period of time, and 
there was a significant decrement in overall performance on 
the Stanford-Binet and the Muller-Lyer Illusion tests, mostly 
because of inability to maintain attention and increased vari­
ability in judgement, respectively. It should be noted, in 
consideration of the meaningfulness of these studies, that 
the subjects participating in them had histories of multiple 
drug abuse and were judged to exhibit considerable psychopath­
ology.
More recently (1972), the National Commission on Marijuana
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and Drug Abuse has conducted several long-term studies using 
rats, monkeys and humans. Since the animal studies were cited 
earlier, only the two human studies will be discussed here.
The first, known as the "Boston 21-Day Free Access Study", 
utilized college student volunteers. The Commission was un­
able to determine any harmful effects on (1) general body 
functions, (2) motor functions, (3) personal or social behav­
ior, or (4) work performance. Increases in total sleep time 
and periods of sleep were uniformly noted, as was weight gain. 
With time, tolerance developed to increased pulse rate, dis­
turbances in time estimation, and decrements in short-term 
memory and shooting-gallery skill, but not to the subjectively 
perceived "high". Risk-taking behavior in decision-making 
tasks became uniformly more conservative. There was no de­
crease in motivation as evidenced by willingness to partici­
pate in a variety of social and goal-directed behaviors (e.g. 
writing, reading, athletic, aesthetic, current events), and 
no consistent change in work performance on simple tasks.
In a second investigation, known as the "Jamaican Study", 
a population of subjects were observed who had used very high 
doses of marijuana for many years. The Commission concluded 
that no evidence of physical dependence could be ascertained, 
although tolerance and psychological dependence did develop. 
"No significant mental or physical abnormalities related to 
marijuana use" were observed, as judged on the basis of medi­
cal history, physical examination, chest x-ray, electrocardio­
gram (EKG), blood cell count and chemistry analysis, lung,
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liver and kidney function tests, selected hormone evaluations, 
electroencephalogram (EEG), and psychological testing.
Although these studies leave much to be desired in data 
reporting and appropriate experimental controls, they do sug­
gest that considerable compensation can occur during the in­
toxicated state, particularly after tolerance or adaptation 
has developed, and that physiological aberrations and decre­
ments in psychological functioning (particularly on tasks mea­
suring short-term memory, general intellectual ability and 
various psychomotor skills) tend to disappear with long-term 
use in relatively "normal" populations. These trends have 
been corroborated by studies of acute intoxication with sub­
jects known to be chronic, heavy users. These will be re­
viewed as part of the following section.
F. Acute Physiological Effects
The author's review of representative studies indicates 
three consistent findings concerning marijuana intoxication:
(1) when it is measured, a marked increase in heart rate (HR) 
is invariably found during the acute phase, (2) distortion in 
the experience of time is frequently reported, and (3) decre­
ments in performance on psychological tests thought to measure 
short-term memory abilities are often observed.
A number of investigations have studied aspects of the 
cardiovascular response to marijuana. Dixon (1899) found an 
initial drop in BP and then a permanent rise, as well as in­
creased HR. He concluded that these phenomena were the result
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of stimulation of the medullary cardiac center and not the 
consequence of peripheral vasomotor mechanisms. The basis 
for Dixon's conclusions are, however, not explained in his re­
port. As will be seen, neither the BP changes nor his con­
clusion of CNS activation have been substantiated in later 
studies.
Williams and associates (1946), in a study cited earlier, 
found large increases in HR and slight increases in BP among 
prisoners either smoking or orally ingesting THC. The BP in­
crease appears to be statistically insignificant and possibly 
the result of measurement artifact. Allentuck (1944) , using 
injected doses of 2 to 22 cc's of "resin", found a similar 
pattern of HR and BP response, as well as no change in a num­
ber of other measures (blood sugar; blood cell count; hemo­
globin, nitrogen, calcium and phosphorous percentages in blood 
samples).
Isbell and associates (1967) compared the relative potency 
of smoked and orally ingested THC injected in tobacco cig­
arettes or dissolved in ethanol. Ten subjects (former opiate 
addicts imprisoned for several months) received in randomized 
order a placebo, 120 and 480 micrograms/kg. orally and 50 and 
200 micrograms/kg. by smoking. Doses were administered at 
weekly intervals to preclude development of tolerance. Re­
gardless of route of administration or dosage, THC caused no 
change in pupillary size, systolic or diastolic BP or knee- 
jerk threshold. Pulse rates were consistently elevated, air 
though specific data on this variable was not supplied by the
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authors.
In studying the effects of music and prior experience on 
a subjective drug effects questionnaire, mood and Wechsler 
Memory Scale performance, Waskow, Olsson, Salzman and Katz
(1970) also measured HR, BP and oral temperature. Either a 
placebo or 20 mg. of THC extract dissolved in 4 cc ethanol 
was given in double-blind fashion to two groups of "emotion­
ally unstable criminal offenders". One group was marijuana- 
naive and the other had had some experience (presumably not 
extensive) with the drug. Unfortunately, measurements were 
made at 1, 2%, 3k, and 4% hours post-injection, thereby mis­
sing the maximal activity of the drug. HR increases averaged 
only 15 beats/minute (b/min) at the one hour interval. Sys­
tolic BP declined from the initial average 113 mm. Hg to 
105 mm. Hg over the 4% hour interval. The change in BP did 
not become statistically significant until the measurement at 
4J5 hours. Since BP was measured in an erect position, the de­
crease may be mostly the result of methodological artifact. 
Statistics for BP were not calculated by comparing the experi­
mental with the placebo group. Although THC subjects reported 
more feelings of euphoria, relaxation, fuzzy thinking, time 
distortion, dizziness, sedation, and body unsteadiness than 
the controls, these differences were not marked. Music had 
no effect on reported effects. Little or no impairment for 
THC subjects on various cognitive tasks (memory for digits, 
counting backward, serial addition) was observed.
Comparing ad lib smoked THC with placebo among heavy
21
(daily) and casual (weekly) college student users, Meyer, 
Pillard, Shapiro and Mirin (1971) found an average increase 
in HR of 11 b/min. when subjects reported being "high".
More marked increases in HR with higher dosages of THC 
have been reported in recent investigations (Dornbush, Fink, 
and Freedman, 1971; Johnson and Domino, 1971; Perez-Reyes, 
Timmons, Lipton, Davis and Wall, 1972) . Perez-Reyes and as­
sociates (1972), using a microsuspension of THC in human se­
rum albumen and intravenous infusion found HR increases be­
tween 20 and 30 b/min. Amount of increase paralleled amount 
of total dosage (29 and 48 micrograms/kg.). Maximum HR ac­
celeration was seen approximately 20 minutes post-injection 
and declined gradually to a point still 10% above baseline 
after 90 minutes when the experiment was discontinued. Sub­
jects were male students in their twenties who had had pre­
vious casual experience with marijuana. Subjective ratings 
of the "high" were taken every five minutes and found to cor­
respond very closely with the increase in HR.
Dornbush and associates (1971) have established a dose/ 
time curve for smoked marijuana using HR as the dependent vari­
able. High (750 mg.), low (250 mg.) and placebo dosages were 
prepared by diluting NIMH marijuana (THC content - 1.5%) with 
oregano. Using a double-blind paradigm, all three dosages 
were randomly administered to ten medical students having simi­
lar histories of marijuana use. HR was measured before and 
immediately after smoking and at 20, 40 and 60 minutes after 
smoking. Greatest increase in HR was found immediately after
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smoking and averaged more than 20 b/min. for the high dosage 
and 2-5 b/min. for the low dosage, whereas a decrease of 
three or four b/min. was observed in the placebo condition.
At 60 minutes after smoking, HR had gradually declined until 
it again approximated the baseline levels.
Kiplinger and associates (Kiplinger, Manno, Rodda and 
Forney, 1971) have provided a dose-response curve for smoked 
marijuana and HR. Using cigarettes calibrated (by diluting 
marijuana with no THC) to deliver doses of 0, 6.26, 12.5, 25 
and 50 micrograms/kg. in a randomized, double-blind design, 
they measured HR at 20 minutes after completion of a standard­
ized smoking procedure. With seven naive subjects and eight 
casual users (all male medical or graduate students) and 
weekly intervals between drug administration, HR was found to 
increase linearly with dosage level.
Johnson and Domino (1971), using continuous, standard EKG 
recording, have also found a linear relationship between dosage 
and HR acceleration. Although standard reporting of dosage in 
terms of micrograms/kg. body weight was not used in this study, 
the authors' measurements were expressed in total dose avail­
able in the cigarettes smoked (range: 1 to 30 milligrams THC).
As in other studies, HR acceleration was found to be dose-
dependent, peaking in 20 to 30 minutes, and having a rate of 
decline inversely proportioned to dosage level. Interestingly,
Johnson and Domino also report a "significant" increase in
both diastolic and systolic BP, related to dosage level.
Again, inspection of the available data does not suggest that
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this finding is a meaningful one since there is considerable 
individual variability, and mean increases and standard devia­
tions are not reported.
In summary, a broad spectrum of research efforts has 
characteristically found HR acceleration to be a reliable con­
comitant of the marijuana "high". When marijuana is smoked, 
this acceleration typically reaches a maximum value in 15 to 
30 minutes, and both the maximum value and rate of decline de­
pend on the dosage level - higher dosages producing greater 
and more prolonged effects. In regard to another cardiovascu­
lar variable, blood pressure, experimental findings are 
equivocal. Over long periods of heavy use, some tolerance to 
the acceleration of heart rate may occur.
The mechanism of marijuana tachycardia remains unclear, 
although a number of possibilities have been suggested.
Johnson and Domino (1971) have suggested increased catechola­
mine release, increased atropine levels and vasodilatation as 
possibilities. Hollister's findings (Hollister, 1972; 
Hollister, Moore, Kanter and Noble, 1970) of uniform absence 
of change in catecholamine excretion, plasma cortisol levels 
and platelet serotonin content during acute marijuana intoxi­
cation, despite the notorious unreliability of such measure­
ments, fail to support most of these hypotheses. On the sup­
position that decrements in cognitive functioning associated 
with marijuana intoxication might be adrenergically-mediated, 
Drew and associates (1972) administered propranolol, a beta- 
adrenergic blocking drug, during a 24-hour period prior to
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marijuana ingestion. Significant decrements in ability to 
shift between two cognitive sets (Reitan Trail Making Test B) 
were noted for both the group receiving placebo propranolol 
and active marijuana and the group which received active pro­
pranolol and marijuana. In fact, the latter group tended to 
make more errors on this task than did the former. Neither 
marijuana nor propranolol, either singly or in combination, 
produced any change in performance on tasks requiring short­
term memory (story recall) or cognitive constancy (Stroop 
Color-Word test). A delivered dosage of only 25 micrograms/ 
kg. was used, however. The beta-adrenergic blocking drug 
certainly did not appear to counteract the psychological ef­
fects of marijuana. No physiological data were reported in 
this study.
The possibility that the marijuana "high" is mediated by 
cardiovascular factors has been raised by Johnson and Domino 
(1971), who suggested vasodilatation as a possibility, and 
Efron (1970). Efron observed the usual HR acceleration with­
out change in BP and concluded that this pattern might be siilai- 
lar to orthostatic hypotension. This is defined as venous 
pooling of the blood in the lower extremities and gut caused 
by changing from a supine position to an erect one. The de­
creased arterial blood supply is followed by compensatory mecha­
nism of HR acceleration and constriction of surface vessels.
If these mechanisms do not sufficiently compensate for the de­
creased arterial supply, the subject loses consciousness.
Such cardiovascular mechanisms have not yet been studied with
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respect to the marijuana "high".
Efron also implicates carbon monoxide intoxication as a 
possible physiological mechanism of the psychological effects 
produced by marijuana. Cardiovascular concomitants of such a 
condition are surface vasodilatation, HR acceleration and in­
creased respiration.
G. Acute Psychological Effects
A number of perceptual changes, typically described as 
pleasurable, are frequently reported by marijuana users in re­
sponding to interview or questionnaire surveys (Tart, 1970,
1972? Halikas, Goodwin and Guze, 1971; Haines and Green,
1970). The most characteristic perceptual changes occurring 
during the marijuana "high" are slowing of the subjective time 
sense, increased auditory ability, increased visual sensitiv­
ity (especially color and pattern perception), increased sen*- 
sitivity to social nuances, increased awareness of propriocep­
tive cues, and either increased (lower levels of intoxication) 
or decreased (highest levels of intoxication) acuity for somato­
sensory cues. Most of these reports have not been confirmed 
by laboratory studies providing data from standardized psycho­
logical and psychophysical tests. Rather than impugning the 
validity of subjective reporting, this discrepancy between the 
survey and the experiment more likely reflects a lack of ade­
quate behavioral discrimination in standard measuring devices.
A number of studies have suggested that, although a ma­
jor symptom cf the marijuana "high" is increased awareness of
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the present and decreased awareness of past and future tempo­
ral relations (Melges, Tinklenberg, Hollister and Gillespie, 
1970, 1971), the perception of subjective time, slows consider­
ably in relation to objective time. In tasks requiring the 
estimation of a brief time interval (usually demarcated by 
some form of auditory stimulation such as a tone or verbal 
material being read, completion of some type of activity such 
as simple mental or motor tasks, or only by the onset and off­
set of a stimulus), experimental subjects invariably estimate 
the duration as being much longer than it objectively is. 
Subjects receiving either nothing or a placebo provide esti­
mates tending to be slightly shorter or slightly longer than 
the actual interval (Weil, Zinberg and Nelsen, 1968; Jones 
and Stone, 1970; Hollister et el, 1970; Hollister, 1971;
Clark, Hughes and Nakashima, 1970; National Commission on 
Marijuana and Drug Abuse, 1972) . Several investigators 
(Meyer, Pillard, Shapiro and Mirin, 1971; Dornbush, Fink and 
Freedman, 1971) have reported negative findings on this vari­
able. However, in each negative case, the task has been for 
S to either reproduce or produce a specified time interval.
The discrepancy may be the result of differential attentional 
demands on the two types of task.
The over-estimation (rather than production) of time in­
tervals longer than a few seconds appears to be a relatively 
consistent and stable phenomenon associated with the marijuana 
"high”. These distortions may be related to disturbances in 
some type of "biological clock", a concept frequently offered
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as a basis for subjective temporal experience (Wallace and 
Rabin, 1960). Although dose-dependent physiological changes 
have been demonstrated as a major characteristic of marijuana 
intoxication, "biological clock" hypotheses have not yet been 
investigated.
Several parameters of auditory and visual perception 
have not been shown to change during marijuana intoxication. 
Morrow (1944) was unable to demonstrate, using the La Guardia 
Commission prisoner population described earlier, any sig­
nificant alteration in auditory acuity or musical aptitude. 
Various natural and synthetic marijuana preparations were 
employed, and Sis were tested on the Gal ton Whistle (acuity) 
and Kwalwasser-Dykerna Tests (ability). Williams and associ­
ates (1946) also obtained negative results for musical talent 
as measured by the Seashore Test. Clark and associates (1968) 
report that accuracy of perception of auditory frequencies was 
unchanged at all dosage levels tested. They do not report what 
psychophysical methods were used; but dosages (.0125, ;02 and 
.03 grams/lb. of crude THC extract in ethanol ingested in cap­
sule form) were moderate to high. It is possible that testing 
was completed before appearance of the effects which is known 
to be delayed by this route of administration. Caldwell, Myers, 
Domino and Merriam (1969) allowed college students to smoke 
marijuana until a subjective "high" had been reached, at which 
time several visual and auditory tests were administered. A 
standard hearing test, auditory intensity and frequency dis­
crimination tasks, and a visual brightness discrimination task
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failed to differentiate between marijuana and placebo groups. 
The authors attributed their lack of findings to an.observa­
tion that Ss were apparently able to turn off the "high" dur­
ing the short periods requiring concentrated attention.
Meyer and associates (1971) gave placebo and ad libitum 
active doses of smoked marijuana to heavy and casual users, 
but found no significant differences between any of the groups 
on an embedded-?igures test. With Ss defined as heavy users 
receiving either placebo or active substances (either smoked 
or ingested as ethanol extract in dosages of 9 mg. THC or 90 
mg. THC and .95 gram/kg. ethanol, respectively), Jones and 
Stone (1970) found no change in perception of verticality as 
measured on the rod and frame test, although characteristic 
HR acceleration was observed as an indicator that dosages were 
effective. Hollister (1970) also failed to find differences 
in rod and frame performance of appropriate placebo control 
groups and experimental groups receiving either ethanol, am­
phetamines, or 0.5 mg./kg. THC. Using moderate doses of 
ethanol-THC extract, Clark and Nakashima (1968) found no dif­
ferences between placebo and experimental Ss on a test of 
depth perception (positioning vertical white rods at 16 feet). 
A slight but significant improvement in vibratory sense appre­
ciation, measured as part of a standard neurological examina­
tion, was found with S£ smoking ad libitum doses of marijuana 
by Rodin, Domino and Porzak (1970).
Marijuana apparently has greater effects on psychomotor 
performance than it does on simpler perceptual processes.
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Two variables, reaction time and visual-motor coordination, 
have received the most attention in recent literature. Weil 
and associates (1968) found a dose-related decrement in Ss1 
ability to track a moving spot on a turntable with a stylus 
(pursuit rotor task). Similar results have been obtained by 
Manno's group (Manno and associates, 1970a, 1970b; Kiplinger 
and associates, 1971) who required S£ to track various wave­
form presented on an oscilloscope. Using §£ in an own-control 
design, Clark and Nakashima (1968) failed to find consistent 
drug effects on pursuit rotor performance using mild oral 
doses of THC. The authors attributed these negative results 
to practice effects observed on the task which tended to ob­
scure possible drug effects. A more likely explanation is 
that marijuana-naive S£, as used in this study, do not show 
changes on the pursuit rotor task. Meyer and associates 
(1971) also report nonsignificant effects of marijuana on 
pursuit-rotor performance of heavy and casual users. From 
the report of their procedures, however, it appears that the 
task may have been administered as late as an hour or more 
after completion of smoking. Nonsignificant trends were re­
ported by this group, with casual users tending to show 
greater performance decrements than heavy users, thus support­
ing the concept of behavioral adaptation.
The evidence for a marijuana-produced decrement (i.e. 
slowing) in psychomotor reaction time is more equivocal. 
Dornbush and associates (1971) measured simple reaction time 
in both visual and auditory modalities by having respond
30
as quickly as possible to presentation of a single auditory
C
or visual stimulus following a variable preparatory interval. 
Reaction time (RT) was significantly slower in both modali­
ties following high doses of smoked marijuana, but a lower 
dosage produced no effect. Hollister and Gillespie (1970) 
varied the length of a tone presentation while Ss kept a tele­
graph key depressed. Upon cessation of the tone, S£ were to 
release the key as quickly as possible. Highly significant 
differences between groups receiving placebo, alcohol, am­
phetamine or marijuana appeared during testing done at one 
hour and three and one half hours post-injection. These dif­
ferences were primarily the result of decrements in the group 
receiving alcohol and increments in the amphetamine group, 
however. Clark and Nakashima (1968) measured hand and foot 
RT to simple (single) and complex (choice) visual signals. 
Although they did not report either a statistical analysis or 
complete data, they concluded that marijuana produced dose- 
related decrements in RT which were larger for choice than 
simple RT. Inspection of the available data, however, sug­
gests that these decrements were not large and probably not 
statistically significant. A better estimate of marijuana 
effects on RT was presented in a later study (Clark and as­
sociates, 1970) in which, more complete data were reported. 
Repeating essentially the same paradigm used in the earlier 
study, these investigators reported no change in average RT 
between drug and placebo conditions. With the drug condition, 
however, marked reaction deficits were seen on individual
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trials which never occurred under placebo conditions. The 
authors concluded that the principle effect of marijuana on 
complex RT is a sporadic impairment of the S's ability to 
maintain a response set.
In short, the available evidence seems to indicate that 
marijuana has little effect on simple RT, and that its detri­
mental effect on complex (choice) RT is probably an increase 
in intraindividual variability associated with sporadic 
lapses in attention. This possibility is in need of further 
confirmation, however.
Attentional deficits, as well as deficits in short-term 
recall, sequencing of mental operations, mental control and 
flexibility have been demonstrated in the extensive litera­
ture on marijuana-induced changes in intellectual function­
ing.
The most consistent marijuana-induced decrements have 
been demonstrated on psychometric variables classifiable un­
der the general rubric of short-term memory, or recall.
Both Halpern (1944) and Tinklenberg et al (1970) report dec­
rements on digit span tasks (immediate recall of increasingly 
longer series of numbers, both forward and backward). Waskow 
and associates (1970) did not find a decrement on this task, 
however. They concluded that digit span was not sensitive to 
the fairly small dose of THC used in their study. A task re­
quiring a somewhat longer period of memory is digit coding, 
which requires S to find one of several unmarked keys which 
is associated with each of a series of numbers appearing in
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random order on a projection screen. Clark (Clark and 
Nakashima, 1968; Clark and associates, 1970) has found 
marked decrements in performance of this task under drug con­
ditions. After smoking marijuana, Ss were unable to achieve 
their pre-drug, baseline performance level after as many as 
300 trials. Dornbush and associates (1971) obtained mixed 
results with a task requiring S to recall three-letter tri­
grams (e.g. DKF) after filled intervals of 0, 6, 12 and 18 
seconds. They found that a low dose group did not differ 
from placebo controls on this task, but that a high dose 
group showed decrements in performance which increased with 
interval length. Recall of short word lists may be too sim­
ple a task to be sensitive to marijuana intoxication, as Abel
(1971) found no change in performance under conditions of im­
mediate free recall or delayed free recall (25 minutes). Per­
formance on the more complex prose recall tasks (Abel, 1971; 
Drew et aJ, 1972) and standardized reading comprehension tasks 
(e.g. Iowa Silent Reading Test; Clark and associates, 1968,
1970) is significantly hampered when Ss_ ingest marijuana.
Performance on visual memory tasks has received surpris­
ingly little attention in the literature, in view of the fre­
quent claims made that marijuana enhances and distorts the 
visual processes and ability to orient in space. The only 
available study in this area is that of Halpern (1944). He 
found decrements in an object memory task (10 objects pre­
sented for 3 seconds on a flat surface) and in a task pre­
sumably requiring the reproduction of designs from memory
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(described only as "Army designs").
In general, these studies suggest that given a suffi­
ciently potent dosage, decrements in short-term memory abili­
ties may be expected even though general intellectual func­
tioning may not be impaired. Abel (1971) has concluded that 
marijuana does not interfere with the retrieval of informa­
tion already stored in the memory, and that impairment in 
memory caused by marijuana occurs because information fails 
to become encoded in the memory stores and is therefore not 
available for retrieval. Neither general intellectual level 
nor previous usage history seem to affect the degree of im­
pairment in performing these tasks during active marijuana 
intoxication. This may not be true of other mental abilities, 
however.
Of the tasks relating in a general sense to intellectual 
flexibility, the Digit Symbol Substitution Test (DSST) has 
been the most widely investigated in relation to marijuana 
intoxication. This task, a subtest of the various Wechsler 
intelligence scales, is probably a measure of the.ability to 
rapidly shift between two cognitive systems as well as of 
manuel dexterity. In this case, previous usage history ap­
pears to be highly relevant to the effects that marijuana 
will have on performance. Evidently, only marijuana-naive 
Ss show significant decrements in performing this task (Clark 
and associates, 1968, 1970; Weil and associates, 1968).
Either casual or heavy users show no loss of ability (Hollister 
and associates, 1970; Meyer and associates, 1971; Jones and
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Stone, 1970). Weil et al (1968) found significant decrements 
in DSST performance of naive S£, but a slight improvement in 
the performance of heavy users which was attributed to prac­
tice effect. Previous marijuana experience could provide op­
portunities for the development of compensatory mechanisms 
relevant to DSST performance. One possibility in this case 
may be that those Ss who have previous marijuana experience 
may have learned to compensate for distortions in spatial 
orientation. Drew and associates (1972) attempted to correct 
for this possibility by using Trails A and B from the Halstead 
battery. They proposed that Trails A is primarily a measure 
of spatial orientation, while Trails B requires this ability 
plus a "set shifting" ability. By subtracting Trails A scores 
(S is required to connect serially numbered dots with a pen­
cil mark) from Trails B scores (S is required to connect dots 
by alternating between alphabetical and numeric series), it 
was reasoned that a purer indicator of mental flexibility 
could be obtained. Ss having a minimal usage history (i.e.
2 or 3 prior experiences) did show decrements in performance 
on this measure. However, the absence of both a naive and 
heavy usage groups in this study still leaves the issue un­
resolved. Another promising task related to this general 
area is one requiring Ss to solve visually-presented, five- 
letter anagrams. Abel (1971) has found that marijuana inges­
tion is associated with significant decrements in perfor­
mances of experienced users.
More consistent results have been obtained on psychometric
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tasks which might loosely be classified as relating to "men­
tal control", or the ability to maintain a cognitive, set over 
time, particularly by disregarding stimuli irrelevant to the 
task. Marijuana seems to affect performance on these tasks 
as a function of task complexity* Simple tasks, such as re­
verse counting (Manno et al, 1970a, 1970b; Kiplinger et al,
1971) and the Stroup color-word interference test (Meyer 
et al, 1971? Drew et al, 1972) do not appear to be affected 
by marijuana ingestion. Tasks of intermediate difficulty, 
such as the solution of simple arithmetic problems (Hollister 
et al, 1970; Manno et al, 1970a, 1970b; Kiplinger et al, 1971) 
may or may not be adversely affected, depending on dosage. 
More complex tasks like serial mental addition (Waskow et al, 
1970? Manno et al, 1970a, 1970b), mental subtraction, pro­
gressive counting (e.g. by "threes" or "sevens"), or repeat­
ing a verbal passage in reverse order (Manno et al, 1970a, 
1970b; Kiplinger et al, 1971) are consistently and adversely 
affected by marijuana.
Finally, it may be possible that many of the decrements 
in performance on the three broad classes of psychometric 
tasks described above may be partially the result of abrupt 
fluctuations in attention associated with marijuana intoxlcar 
tion. Evidence for these fluctuations has been reviewed ear­
lier in connection with questionnaire surveys and RT experi­
ments. One method used to study this possibility has been to 
observe behavior on the Continuous Performance Test (OPT).
This task involves the rapid, visual presentation on a screen
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of various letters of the alphabet. S 's job is to press a 
key each time a specified letter appears on the screen. Weil 
and associates (1968), using §£ identified as chronic users 
and marijuana-naive, found no decrement in CPT performance in 
either group after ingestion of low and moderate dosages of 
smoked marijuana. Meyer and associates (1971), however, have 
found marked decrements in performance for casual (but not 
heavy) users under the marijuana condition (five times the 
number of omission errors as in the placebo group). The dos­
age here was ad libitum and quite potent. Heavy users' per­
formances did not differ significantly from those of a placebo 
group. It may be that there exists a dosage-behavioral toler­
ance interaction effect of marijuana on sustained attention; 
Although systematic experimental evidence for such an explana­
tion is presently lacking, there are many suggestions (Grinspoon, 
1971; Tart, 1971? Isbell et al, 1967) that these attentional 
fluctuations have a voluntary component.
In summary, the literature provides considerable infor­
mation about the chemical, pharmacological, toxicological, 
epidemiological and phenomenological aspects of marijuana. 
Physiological evidence concerning the fundamental (and as yet 
unanswered) question of mechanisms of action, has been pre­
dominantly negative, i.e. it has suggested that a number of 
parameters are not affected by marijuana ingestion. One rea­
son for this state of affairs may be that individual variables, 
rather than systems of parameters, have tended to be the focus 
of attention in studies where physiological measurements were
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taken. Knowledge of psychological characteristics of mari­
juana intoxication is similarly fractionated, both in terms 
of its-relation to physiological substrates and as a result 
of several methodological difficulties. Considerations such 
as set, setting and previous experience with the drug are not 
yet fully elucidated. Psychologically-oriented studies of 
the acute effects of marijuana intoxication have tended to 
focus on changes in one or two circumscribed areas of human 
functioning. Evidently, only the long-term investigations 
have been afforded the luxury of observing a broad represen­
tation of psychological abilities and capacities thought to 
be sensitive to the effects of marijuana, but often at the 
expense of methodological rigor.
A psychophysiological approach to the problem of acute 
marijuana intoxication could be conceptualized as relating 
change in a system of psychological parameters, representa­
tive of several distinct areas of functioning, to change in 
a system of physiological parameters. Such an approach might 
provide an efficient method of specifying and relating poten­
tial mechanisms of action of marijuana.
H. Rationale and Purpose of the Study
The general purpose of this investigation was to examine 
some of the psychological and physiological consequences of 
marijuana ingestion in order to (1) better define the psycho- 
physiological correlates of marijuana intoxication, (2) evalu­
ate the possibility that a cardiovascular etiology, i.e. cere­
bral ischemia, could provide a physiological explanation of
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psychological aspects of marijuana intoxication and (3) study 
the resemblance of these psychophysiological relationships to 
those previously observed in similar conditions, e.g. mild 
anoxia and other mild cerebral ischemic states. A more de­
tailed background and rationale is presented below, in order 
to develop specific hypotheses concerning the psychological 
and physiological variables chosen for this study.
Previous investigations have shown that A1THC is almost 
the sole psychoactive component of marijuana, and that speci­
fied dosages of this substance can be approximated when mari­
juana is smoked under controlled conditions. Furthermore, 
acute marijuana intoxication in the human can be characterized 
by reliably-observed alterations in physiological and psycho­
logical . functioning, although alterations of the latter ap­
pear to depend extensively on the subject's past experience 
with marijuana. However, attempts at establishing psycho- 
physiological relationships, particularly the elucidation of 
physiological mechanisms which could mediate the psychologi­
cal effects of acute marijuana intoxication, have been largely 
unsuccessful. The most common physical symptom of marijuana 
intoxication appears to be a marked change in cardiovascular 
functioning, i.e. heart rate acceleration. Although a dose- 
response curve has been approximated for this variable, other 
aspects of the hemodynamic system have either not been ob­
served, or observation has yielded inconclusive results (as 
in the case of systemic blood pressure).
The hemodynamic system serves several basic functions
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(King and Showers, 1963): (1) respiratory (conveying oxygen
from the lungs to the cells and carbon dioxide from the cells 
to the lungs); (2) nutritive (carrying basic materials, such 
as glucose, from the digestive tract to the cells); (3) excre­
tory (transporting waste products of nitrogenous metabolism 
to the organs of excretion); (4) regulatory (distributing hor­
mones, maintaining stable concentrations of water and other 
substances, equalizing body temperature and giving off heat 
from the superficial vessels); and (5) protective (carrying 
white blood ceils and various immune substances). In short, 
cellular efficiency is directly related to adequacy of the 
blood supply. This is particularly true of the brain, since 
it requires, for example, nearly 20% of the oxygen available 
to the entire organism, although it comprises only 2 to 3% 
of the total body weight (Ruch and Fulton, 1960, p. 742) . 
Relatively small decreases in the cerebral blood supply have 
been shown to produce qualitative impairment of psychological 
and neurological functioning (Schade and McMenemey, 1963).
As noted previously, both Shagass (1966) and Efron (1970) 
have suggested that marijuana intoxication may produce changes 
in the cardiovasculature which are similar to those found in 
cases exhibiting orthostatic hypotension. Similarly, 
Shmavonian (1971) has suggested that the marijuana-induced 
changes in psychological functioning may be the result of 
cerebral ischemia.
Further clarification of these hypotheses is provided 
by the interrelationships among the principal hemodynamic
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parameters. Since the hemodynamic system is a closed system, 
the local availability of blood (i.e., perfusion) can be ex­
pressed by the equation P = BPA / RL (Hurst and Logue, 1970; 
Kelman, 1971) where B3?A represents mean arterial blood pres­
sure and Rl is local resistance of the vasculature.' R^ is 
primarily the result of the diameter and elasticity of the 
arterioles (small vessels connecting arteries to the capil­
lary bed) which provide about 80% of the total resistance in 
the hemodynamic system. Mean arterial blood pressure is de­
fined by the equation BP^ = CO X PR where CO represents car­
diac output (the volume of blood pumped by the left ventricle 
per unit time) is expressed in terms of the equation CO = SV 
X HR where SV represents stroke volume (ml/beat) and HR is 
heart rate in beats/min. Since SV does not show a major de­
crease unless HR is extremely accelerated, e.g. 150 beats/min., 
CO is generally considered to be predominantly a function of 
HR, within wide limits.
In accordance with the perfusion equation, an increase 
in local resistance accompanied by no change in BP& should 
result in decreased perfusion. Furthermore, observation of 
no change in mean arterial blood pressure and increased PR 
would suggest a decrease in CO, despite HR acceleration. Fol­
lowing the lines of inductive reasoning independently sug­
gested by Shagass, Efron and Shmavonian, one might hypothesize 
that marijuana may effect a state of decreased perfusion and 
that this hypothesis would be supported by observation of di­
gital and cephalic vasoconstriction and heart rate acceleration
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with no increase in mean blood pressure or change in respi­
ration .
Changes in these cardiovascular variables following 
marijuana ingestion have been the subjects of considerable 
speculation and rumor, which presumably have been based on 
clandestine observation.
Inspection of Fig. 1 shows how such reputed changes in 
the cardiovascular responses from baseline to intoxicated 
states might look on the polygraph record: (1) HR accel­
eration from approximately 60 beats/min. to 120 beats/min.,
(2) digital and cephalic pulse volumes decrease to approxi* 
mately half of the baseline value, and (3) respiration re­
mains unchanged. These changes were rumored to be very con­
sistent.
These observations suggest that the relationship of psy­
chological effects to a sustained state of cerebral ischemia 
is a promising avenue of further investigation aimed at elu­
cidating the actions of this drug.
Several inferences may also be drawn from the literature 
concerning psychological symptoms of acute marijuana intoxi­
cation. Cognitive functioning, particularly intellectual 
skills heavily dependent on short-term memory, tend to be 
consistently and adversely affected during marijuana intoxi­
cation. Basic perceptual skills, however, are evidently 
neither improved nor hampered by the drug. A number of in­
vestigations have, for example, failed to confirm reports of 
changes in visual perception during marijuana intoxication.
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Cardiovascular measures on a single subject 
before and after smoking marijuana (Resp.= 
respiration; HR=heart rate; DPV=digital pulse 
volume; CPV=cerebral pulse volume).
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As noted previously, only Halpern (1944) has directly inves­
tigated the effects of marijuana on complex mental functions 
which, depend primarily on the visuo-spatial systems of the 
Central Nervous System (CNS). One might infer that the 
changes in visual perception popularly claimed as. side ef­
fects .of marijuana ingestion are predominantly the result of 
impairment of higher-order integrative and analytical skills 
rather than alterations in basic visuo-spatial perception.
An intent of the present investigation was to monitor changes 
in higher-order, visually-mediated mental processes during 
acute marijuana intoxication with the expectation that decre­
ments in these skills would be observable as concomitants of 
physiological changes produced by the drug.
Psychomotor reaction time (RT) has frequently been mea­
sured during laboratory investigations of marijuana intoxica­
tion, with inconclusive results. One possible interpretation 
of thi6 inconsistency has been suggested by Clark and associ­
ates (1970): changes in RT performance during marijuana in­
toxication are not likely to.be observed.in relation to psy­
chomotor speed, but are more likely to be observed as a decre­
ment in S's ability to maintain an attentional or response 
set. That is, although the drug may produce no change in mean 
psychorootor speed, one might expect an increase in the vari­
ability of performance as a consequence of increased vari­
ability in attention. Observation of the RT variable was of 
interest in that it might provide an indicator of attentional. 
efficiency in a systematic attempt to study a broad range of
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psychological parameters which might be sensitive to inges­
tion of marijuana. A second reason for the incorporation of 
an RT paradigm was that it provided a method of regulating 
internal and external events (e.g. what S was thinking, doing 
and perceiving). The RT paradigm maintains some degree of 
consistency in S ’s experience over time, thereby alleviating 
some of the difficulties in the standardized collection of 
physiological data.
The concept of anxiety has not been evaluated in the ex­
isting literature on marijuana, despite frequent claims that 
the drug has sedative and euphorogenic emotional effects. 
Spielberger (1966) and Cattell and Scheier (1958) have dif­
ferentiated two types of anxiety: trait anxiety (which re­
flects the residual of past experience, and represents anxi­
ety proneness) and state anxiety (moment-to-moment anxiety 
dependent on sensory and cognitive feedback, representing a 
signal function). If marijuana does have sedative properties, 
the experience of state anxiety should be lessened during 
acute intoxication. A second reason for interest in monitor­
ing changes in anxiety was related to the design characteris­
tics of the study. Since complex mental functioning was to 
be measured during an abnormal physiological state, measure­
ment of anxiety was essential as a control. Otherwise, any 
decrement in performance during intoxication could be attri­
buted to the debilitating effects of subjective anxiety rather 
than to the expected physiological changes.
The perception of subjective time is the only perceptual
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variable, at this point, that has reliably shown change dur­
ing marijuana intoxication. The literature suggests that es­
timation, but not production, of a time interval shows in­
creased error in the direction of overestimation during mari­
juana intoxication, particularly when the actual intervals 
are of several minutes duration. This finding correlates 
well with subjective reports that a few minutes may seem like 
hours during acute intoxication. Although invocation of a 
’'biological clock" hypothesis is tempting in view of the HR 
acceleration reliably observed as a characteristic effect of 
marijuana, distortions in time perception have not been in­
vestigated in relation to physiological changes during mari­
juana intoxication. Again, the primary criteria for selecting 
psychological variables for study were (1) indications that 
they might be reliable discriminators between drug and placebo 
conditions and (2) that they represented a broad spectrum of 
psychological functions which could be related to a system of 
physiological variables in subjects differing in terms of in­
gestion of either active or placebo marijuana.
X. Hypotheses
1. Ingestion of THC by smoking marijuana produces the 
following pattern of physiological changes which, in turn, may 
result in a transient state of mild cerebral ischemias
a. cephalic vasoconstriction
b. either no change or a decrease in mean arterial 
blood pressure
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c , digital vasoconstriction
d. heart rate acceleration
2, These marijuana-induced physiological changes are 
concomitant with observable alteration in the quality of psy­
chological functioning, as evidenced by:
a. impairment of short-term memory functions on 
a visual task
b. increased variability of psychomotor perfor­
mance involving choice
c. acceleration of subjective time perception in 
relation to objective time
d. enhancement of a sense of well being through 
the reduction of situationally-determined 
anxiety
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Methods
General Design
This investigation comprised a 2 X 2 factorial, multi- 
variate experiment designed to test a number of directional, 
inferential hypotheses concerning changes in systems of phys­
iological and psychological variables resulting from marijuana 
ingestion. The among Ss variable was smoking either active 
or placebo marijuana. The within Ss variable was repeated 
measurement over time (before and after smoking). Double­
blind procedures were followed throughout, and each S served 
as his own control.
Subjects
Twenty white, male volunteers between the ages of 19 and 
30 were recruited from the student populations of Louisiana 
State University and the Louisiana State University Medical 
Center. All Ss were selected on the basis of their responses 
to a marijuana usage questionnaire (Appendix A) and were not 
informed that a study was to be conducted until data on usage 
was collected. The questionnaire data allowed the selection 
of only those Ss who had had recreational experience with 
marijuana (must have smoked marijuana for at least six months 
but not more them once or twice weekly). Respondents who re­
ported any history of multiple drug abuse, cardiovascular ab­
normalities, "bad trips", or psychiatric difficulties were 
not considered in the final selection process. Final selec­
tion was based upon an interview with each prospective S
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which was conducted by E and a licensed clinical psycholo­
gist. S£ were questioned in detail about their drug habits 
and responses to marijuana, as well as their general health 
histories. Agreement of both interviewers was necessary to 
include a volunteer in the S population. Informed consent 
was obtained from each S and S*s anonymity was guaranteed 
throughout the study. Each S was identified only by a code 
consisting of his first name, middle and last initials.
Prior to participation in the experiment, each S was required 
to sign an informed consent form which was then placed in a 
sealed envelope identified only by S's code. The sealed en­
velopes were to be kept for one year by E and then destroyed 
unopened. Ss were randomly assigned in double-blind fashion 
to either the experimental (n = 10) or control (ri - 10) groups 
according to a master schedule prepared and kept independently 
of those conducting the experiment. The experimental code 
was maintained until all data were collected. In the event 
that a S's data was invalidated, either through procedural er­
ror or natural causes, his code was given to the person keep­
ing the master schedule, and a replacement S was selected 
from the potential subject pool obtained on the basis of the 
questionnaire. The replacement was interviewed and assigned 
to the original S's place in the master schedule if he passed 
the screening procedures outlined above.
Apparatus
Subjects were tested in an 80 decibel, sound attenuated 
and electrically shielded chamber having a one-way mirror
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v/hich allowed viewing from an adjoining equipment room. Com­
munication between the two rooms was provided by a public ad­
dress system. Stimuli for a disjunctive (choice) reaction 
time (DRT) paradigm were presented with BRS Poringer Digibit 
Logic units. Physiological recording was accomplished with 
a Grass Model 7 polygraph equipped with appropriate bridges, 
preamplifiers and driver amplifiers. The voltage or resis­
tance measures were written out on Grass oscillographs for 
graphic representation of physiological activity. In addi­
tion, these measures were converted from analog to digital 
form with an in-line Program Data Processing PDP12 laboratory 
computer. Data samples were scored manually from the poly­
graph record, both during a baseline period and after S 
smoked either placebo or active marijuana. Each sample was 
a 20-second segment of ongoing physiological activity begin­
ning five seconds after termination of Is in a DRT trial. 
Samples were taken after every tenth DRT trial, and each 
sample was immediately followed by a measurement of BP in 
order to insure that all physiological data would be con­
tiguous in time.
Intellectual Functioning
The Benton Visual Retention Test (BVRT.; Benton, 1963) 
was. utilized in the investigation as a means of studying the 
effects of. marijuana on visually-mediated, higher-order men­
tal processes. The BVRT is sensitive to visuo-constructive 
and short-term visual recall abilities, and in addition pro­
vides an estimation of general intellectual functioning.
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Further considerations in its selection were the qualitative 
scoring system (in addition to the quantitative system) which 
allows speculation about the localization of dysfunction, and 
the provision of equivalent forms. Form C and D were adminis­
tered to each S in alternating series. Half of the Ss re­
ceived Form C initially, and then Form D at a later time dur­
ing the experiment. For the remaining S£, this order was re­
versed. The administration procedure for both forms was al­
tered in order to increase the difficulty of the task for a 
college student population. Each design was presented for a 
period of one second. Only after a 30-second delay was the 
S allowed to begin his reproduction. All other procedures 
followed those given in the test manual.
Anxiety
The State-Trait Anxiety Inventory (Spielberger, Gorsuch 
and Lushene, 1968) provides a method of examining potential 
effects of marijuana on situationally-determined anxiety.
Both placebo and drug groups were evaluated for initial dif­
ferences in anxiety-proneness and situationally-determined 
anxiety at the beginning of the experiment. A readministra­
tion of the State-Anxiety scale following the experimental 
manipulation allowed an estimation of the drug effects (both 
the active and placebo marijuana) on this variable.
Reaction Time
A disjunctive reaction time (DRT) procedure with fixed 
foreperiod (four seconds between warning and imperative
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signals) and variable intertrial interval was employed. The 
psychomotor response to the imperative stimulus was pressing 
a telegraph key with the right index finger. Warning sig­
nals (Ws) for both GO (circle) and NO-GO (square) trials 
were geometric figures presented on a small rear projection 
screen. The imperative stimulus (Is) consisted of a 750 Hz 
pure tone of moderate intensity. Twenty-five GO (key press) 
and 25 NO-GO (no press) trials, in a sequence randomized by 
a PDP12 laboratory computer were presented during a baseline 
control period and again after S had smoked marijuana. RTs 
obtained during GO trials were measured on a Hewlett Packard 
Electronic counter calibrated in milliseconds.
Time Perception
During the baseline and again during the drug conditions, 
Ss were asked to estimate the length of a time interval hav­
ing an actual duration of two minutes. The interval was de­
marcated by the experimenter (E) saying "start" and "stop". 
During the timed interval, E observed the stopwatch and did 
not interact with S. After presentation of the interval, E 
asked S to estimate the duration in minutes and seconds.
Heart Rate
Grass E105 cup electrodes containing EKG Sol were placed 
at the fourth intercostal space of the lower left rib cage 
and on the right collarbone. The EKG signal was amplified 
by a Grass 7P4 Tachograph Preamplifier, which converted the 
raw wave complex into a beat-by-beat analysis expressed as
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HR in beats/min./second. This measure was converted to an 
electrical analog written out on a Grass oscillograph. Dur­
ing any given observation period, HR was expressed in terms 
of two scores: the lowest and highest rates for a particular
S. A complete cardiac cycle produces an electrical waveform, 
or Q-R-S-T complex, using these methods. The basis for cal­
culation of beat-to-beat changes in HR was the R-R time in­
terval .
Digital Pulse Volume (DPV)
A transilluminating plethysmograph, consisting of a cry­
stal photoresistor and opposing light source mounted in an 
adjustable aluminum ring, was placed on the moon of the 
fourth fingernail of the left hand. Construction, measure­
ment and recording characteristics of this instrument have 
been described by Shmavonian (1959). The resulting electri­
cal analog of changes in tissue opacity (e.g. blood volume) 
was amplified and written out on a Grass oscillograph.
Cephalic Pulse Volume (CPV)
A reflectance plethysmograph was mounted in an aluminum 
plate, and this unit was taped above the right eyebrow. This 
instrument is a modification of the transilluminating plethys­
mograph and is adapted for use on the forehead, since it pro­
vides an electrical analog of changes in the amount of blood 
present in the tissues between itself and the skull. Measure­
ment and recording characteristics of the CPV variable were 
similar to those of DPV.
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Respiration (Resp.)
A thermistor was placed in the left nasal airstream. 
Changes in the temperature of this sensing device which were 
produced by S's inhalation (cooler) and exhalation (warmer) 
resulted in corresponding changes in resistance of this in­
strument to passage of a small electric current. Resulting 
variations in voltage, with suitable amplification, were 
written out with a Grass oscillograph. This measure was 
taken primarily as a means of checking on extraneous sources 
of variance (e.g. S's engaging in abnormal respiratory ma­
neuvers) which would distort other physiological data.
Second, observation of respiratory activity before and after 
ingestion of marijuana was, in itself, germane to the design 
of this study as previous investigations (Hollister, 1971; 
Weil, 1968; Isbell and associates, 1967; Williams and as­
sociates, 1946) have yielded inconclusive results for this 
variable when it was measured. Third, observation of chronic 
changes in respiratory activity (excluding such artifacts 
as valsalva maneuvers, which result in temporary depression 
of cardiac activity) might suggest alteration of the partial 
pressures for oxygen and carbon dioxicj?: in the bloodstream.
Blood Pressure (BP)
A standard Taylor pressure cuff was placed on the upper 
left arm. This cuff could be remotely inflated and deflated 
by E in the adjoining room. Pressure output from the cuff 
was fed to a Grass 7P8B Sphygmomanometer Pre-Amplifier which
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transformed pressure variations into a variable-voltage elec­
trical signal driving a Grass oscillograph. A graphic repre­
sentation of cuff pressure in iran/Hg was produced by these 
methods. Each BP observation involved inflating the cuff tb 
a pressure of 200 mm/Hg and then slowly bleeding off pres­
sure until the anachrotic limb of the DPV could be visually 
observed on the polygraph record. The pressure point at 
which DPV anachrotic limb first reappeared was used as a mea­
sure of systolic BP. With further bleeding of cuff pressure, 
the dichrotic notch of the DPV later appeared, and was taken 
as a measure of diastolic BP. These methods produced BP read­
ings which were probably more accurate than the clinical aus­
cultatory method which depends on the E 1s auditory abilities.
Marijuana
Material. Ten marijuana cigarettes containing approxi­
mately 1.1% THC and ten placebo marijuana cigarettes (from 
which all THC had been extracted) were obtained through the 
National Institute of Mental Health (NIMH). This material 
had been assayed in NIMH facilities prior to shipment. In­
dividual cigarette weights varied between 800 and 1000 rig.
-Security Procedures. According to a master schedule 
for randomization, one cigarette containing either active or 
placebo marijuana was dispensed to E 15 minutes prior to ex­
perimental use. After use, the remaining butts were weighed 
and stored for further analysis. All marijuana was stored 
in a Protectale SMNA, Class D safe which was kept inside a
55
locked metal vault weighing approximately 2000 pounds. This:* 
storage facility was located in the Pharmacology Department 
at the Louisiana State University Medical Center. Only the 
person responsible for dispensing the cigarettes and the de­
partment chairman had access to this area. Through arrange­
ment with the Department of Psychiatry, medical coverage was 
available at all times during the experiment..
Dose Regimen and Route of Administration. The ten Ss 
comprising the experimental group each smoked one marijuana 
cigarette containing 1.1% THC; the ten S£ comprising the con­
trol group each smoked one placebo marijuana cigarette. All 
Ss were asked to smoke the cigarettes according to a standard 
procedure by inhaling deeply and holding the smoke in the 
lungs for approximately 20 seconds prior to exhalation. Pre­
vious studies (Manno and associates, 1970) have shown that 
this standard form of smoking delivers approximately 50% of 
the THC content of a cigarette to the lungs. A suture clamp 
was provided so that the cigarettes could be smoked to the 
shortest possible butt.
Procedure
A time schedule for the experiment is presented in Table
1, All Ss were tested in the afternoon. Upon arrival at the 
laboratory, each S was advised of the general nature of the 
study. He was told that a number of surface electrodes would 
be placed on his skin and that he would be asked to perform 
various tasks such as pressing a telegraph key or making draw­
ings from memory while his physiological activity was being
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recorded. S was informed that at a halfway point in the ex­
periment, he would be asked to smoke a marijuana cigarette 
which might or might not make him "high". All Ss had previ­
ously been asked not to ingest any drugs during a 24-hour 
period preceding the experiment. At this point, it was ascer­
tained that S had complied with this request. Each S was 
asked if he had any question, and these were answered without 
revealing specific design details. S was also advised that 
E would give him a full explanation of the study after data 
collection was completed. Electrode placement and administra­
tion of the Trait Anxiety Scale was accomplished in a small 
anteroom adjoining the experimental chamber. S was then 
taken into the chamber, seated in a reclining chair and asked 
to assist in adjusting the key and rear projection screen for 
his comfort. Operation of the two-way communication system 
and pressure cuff was explained, and S was asked to relax un­
til the beginning of the experiment. He was told that E 
would leave the room to check operation of the equipment and 
would either return to adjust the electrodes or would communi­
cate with S over the loudspeaker. E then sealed the room, 
made an equipment check,, and read the following instructions 
over the intercom:
1 (S 1 s first name) , keep your eyes on the X in front 
of you. You will see either a circle or a square 
appear around the X. A short time later you will 
hear a tone. When the tone follows the circle, 
press the key with your right index finger as 
fast as you can after the tone begins. When the 
tone follows the square, do not press the key.
Please try to keep movement minimal. During the 
interval between the circle or square and the tone,
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do not blink or move your eyes. Keep your eyes 
open and especially resist the tendency to look 
down at the key. Do you have any questions about 
what you are to do?"
Questions were answered by repetition of an appropriate sec­
tion of the instructions. Fifty DRT trials (25 GO and 25 NO- 
GO) , each initiated by E, were then presented. Any. irregu­
larities in S1s responding (usually body movement, eye blink­
ing during the Ws-Is interval, or pressing the key too soon 
or not at all) were called to S ’s attention and appropriate 
sections of the instructions were again repeated, over the 
intercom. After every tenth DRT trial a BP reading was taken.
After completion of the DRT and BP series, E reentered 
the chamber and informed S that he was to engage in a number 
of tasks before beginning the second half of the experiment. 
The State-Anxiety Inventory was administered while E obtained 
a marijuana cigarette from the Pharmacology Department. S 
was then asked to estimate a two-minute time interval and, 
following this, either Form C or D of the BVRT was adminis­
tered to him. Upon completion of the BVRT S was instructed 
in the smoking procedure, and then smoked the marijuana ciga­
rette to the shortest possible butt using the suture clamp.
The butt was then weighed and stored for analysis. S was 
asked not to offer any comment on the quality of the mari­
juana until the end of the experiment.
Immediately after completion of the smoking procedure, S 
was informed that the second half of the experiment would be­
gin and that it would be a repetition of the first half.
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After recording physiological activity during a second DRT 
series and readministration of the State-Anxiety Inventory, 
time estimation task and BVRT, S was taken from the chamber 
to the adjoining room for removal of electrodes. During this 
time he was asked to describe his experience and to rate his 
level of intoxication on a five-point scale. His physiologi­
cal responses on the polygraph record were explained, and any 
questions were answered. £ was instructed that his anonymity 
would be protected and asked not to discuss the study with 
anyone. He was also instructed not to drive a car, engage in 
any strenuous activity or activities which might endanger the 
lives of others as a result of his condition, for the follow­
ing 24 hours. S was then sent home on public transportation, 
at E's expense.
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Table 1. Procedure Sequence
Time (hrs/min) Event
0.00 Subject arrival at laboratory
0.00 Design explanation; Trait-Anxiety Inventory
0.00 Signing of informed consent form
0.10 Electrode placement
0.45 Chamber hookup and familiarization
0.50 DRT series
1.50 State-Anxiety Inventory
2.00 Time interval estimation
2.03 Benton Visual Retention Test
2.23 Marijuana smoking
2.38 DRT
3.38 State-Anxiety Inventory
3.43 Time interval estimation
3.48 Benton Visual Retention Test
4.08 Cleanup and release
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Results
A. Physiological Data Reduction
Each S's polygraph record was manually scored for each 
variable during each of the 20 observation trials (10 prior 
to smoking and 10 following smoking). Following scoring pro­
cedures outlined below, scores for each variable for each ob­
servation were derived by averaging the respective physio­
logical activity for that 20-second interval. Each 20-second 
interval was divided into four subintervals of five seconds 
duration. These five-second subintervals provided the raw 
data enabling the computation of an average score for a given 
variable during each 20-second observation. For a given S 
and a given variable, a composite mean score for an entire 
period (before smoking = Period 1; after smoking = Period 2) 
was derived by computing an average for the respective 10 ob­
servation trials. The composite means, each based upon 40 
raw data scores per subject per period served as the basic 
data units for tabular and graphic presentation and statisti­
cal analysis.
Heart Rate. Heart rate by trial was represented by the 
average minimum and average maximum HRs occurring during each 
20-second observation trial. Two mean HRs by period were de­
rived by averaging either the 10 minimum HRs (HRMINAVG) or 10 
maximum HRs (HRMAXAVG) during the period in question for the 
S in question. Each S was therefore assigned four HR scores, 
one HRMAXAVG and one HRMINAVG for both Period 1 and Period 2.
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Those variables are expressed as beats/minute.
Cephalic Pulse Amplitude. This variable was reduced in 
much the same manner as HR, with the exception that each iS 
was assigned only one averaged score (CPA_AVG) per period.
The height of the anachrotic limb of the pulse pressure wave, 
from the point at which the initial rise occurred to the peak, 
served as the basic raw data unit. This scoring technique 
has been described by Hadjiev (1968), and results based there­
on have been found to yield high correlation (0.81) with si­
multaneous data obtained by radioisotope venous dilution 
methods, suggesting that the CPA provides a reliable indi­
cator of cerebral vascular resistance. As an intermediate 
step between raw data and the derived CPA_AVG, both CPAMAXV 
and CPAMINAV scores (analogous to HRMAXAVG and HRMINAVG de­
rivations, respectively) were computed and averaged to yield 
CPA__AVG. The unit of measurement for this variable is ex­
pressed as millimeters of oscillograph pen deflection.
Digital Pulse Amplitude. The data reduction techniques 
and units of measurement for this variable are essentially 
the same as for CPA. A DPA_AVG score was. derived for each S 
for each period by averaging the corresponding DPAMAXAV and 
DPAMINAV (again analogous to HRMAXAVG and HRMINAVG.
Blood Pressure. The systolic and diastolic blood pres­
sures, obtained for each S immediately following each observa­
tion trial, were averaged separately over trials within peri­
ods to yield one average systolic pressure score (SYSBPAVG) 
and one average diastolic pressure (DIABPAVG) per S per period.
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T h e s e  v a r i a b l e s  are expressed as millimeters of mercury (mm. 
Hg,),
Respiration. This variable was visually monitored on 
the polygraphic record as a check on unusual respiratory 
maneuvers which would invalidate other physiological measure­
ments contiguous with such artifact. Visual inspection 
yielded only infrequent phasic changes of a few seconds dura­
tion, and no tonic alterations in either frequency or depth 
of respiration for all S£. Since these impressions followed 
the conclusions reached by Vachon, Muiris, Fitzgerald, 
Solliday, Gould and Gaensler (1973), no further analysis of 
this variable was deemed necessary.
Dosage. The marijuana used in this study was initially 
assayed at Food and Drug Administration (FDA) facilities and 
reported to contain 2.2% A1THC in the active material and 0.0% 
A*THC in the placebo material. Because of previous reports 
in the literature concerning substantial error•in the federal 
assays, an independent assay was conducted by Joseph Manno, 
Ph.D. in his facilities at Shreveport, Louisiana. This assay 
was conducted immediately following this investigation and 
utilized small samples clipped from each of the 20 cigarettes 
prior to smoking as well as whatever material remained fol­
lowing smoking. This analysis yielded an average A1THC con­
tent of 1.062% for active material, nearly half that estimated 
in the federal analysis, and 0.0% for placebo material. The 
results of the independent analysis were deemed more accurate 
than the federal analysis since HR increases observed in the
63
present study agreed very closely with studies cited earlier 
which employed comparable dosage levels.
After samples were clipped from each cigarette for in­
dependent analysis, each cigarette was weighed. Following 
smoking, the remaining butts were also weighed. The discrep­
ancy in the two measurements multiplied by 0.5 (using the 50% 
approximation rule devised by Manno and associates, 1970, 
cited earlier) and again by 1.062% yielded an estimate of 
total amount of active material consumed by each experimental 
subject. Division of each amount by the body weight of the 
corresponding subject yielded a dosage expressed as micro­
grams per kilogram body weight (yg/kg). The average dosage 
for experimental Ss was 51.29 yg/kg with a range from 41.72 
to 61.80 yg/kg. These, then, were relatively low dosages, 
roughly within the threshold range (25 to 50 yg/kg) specified 
by Grinspoon (1971) and well below the perceptual dosage 
range (around 100 yg/kg) at which visual illusions are fre­
quently reported for smoked marijuana.
B. Psychological Data Reduction
DRTs from the 25 GO trials within each period were 
averaged to provide pre-smoking and post-smoking mean reaction 
times (DRT_AVG) for each S. These scores are expressed in 
milliseconds. A second DRT score, the total number of GO 
trials v/hich were completely missed (DRTMISS) by S during 
both periods, was also computed as a measure of attentional 
fluctuation. This latter score has a possible range of 0-50.
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Only single scores for each period were collected for the 
following variables: State-Anxiety (STATEANX), Time
Estimation (TIME_EST, expressed as estimated number of 
seconds), number of correct reproductions on the BVRT 
(BVRTCOR, possible range: 1-10) and total number of scored
errors on the BVRT (BVRTERR, possible range: 0-more than
20), Also, only one Trait-Anxiety score was obtained for 
each S (TRAITANX). Since this variable does not show sig­
nificant short-term fluctuations, it was utilized to assess 
equivalency of the drug and placebo groups as to anxiety- 
proneness. Similarly, it was reasonable to obtain only one 
subjective rating (RATING, possible range: 1-5) of the mari­
juana "high" from each S.
These measurements of psychological and physiological 
variables, as derived above, comprised the basic data for 
further statistical analyses.
C. Data Analysis and Presentation
Group means and standard deviations on each psychological 
or physiological variable were computed for Dosage X Periods 
and are presented as Table 2. Only single values exist for 
TRAITANX and RATING, and these are arbitrarily entered in the 
post-smoking column.
The system of variables (excepting TRAITANX and RATING, 
for which only single scores were available) was subjected to 
a multivariate analysis of variance (MANOVA). The results of 
this analysis are presented as Table 3. This MANOVA indicates
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highly significant changes in the entire variable system be­
tween the pre-smoking and post-smoking period (Period Main 
Effect, F=*9. 45, p<.005), and nonsignificant differences be­
tween the experimental and placebo groups collapsed across 
periods (Dosage Main Effect, F*3, p<.06). Most importantly, 
the interaction term (Period X Dosage, F=6,98, p<.01) indi­
cates that a significant portion of the variance in this 
multivariate system is accounted for by the unique combina­
tions of dosage and time of measurement.
Specific indications of the direction (or directions) 
of change and identification of variables having major con­
tributions to the attributable variance of the system as a 
whole were obtained with repeated measures analyses of vari­
ance (ANOVA) compiled for each variable (except RATING, 
TRAITANX, and DRTMISS where simple ANOVA was used). These 
ANOVAs are discussed below with respect to the significance 
and predicted direction of change for each variable.
Heart Rate. Initial differences in fast beat HRs 
(HRMAXAVG) between active and placebo groups were not statis­
tically significant (Tukey's "a"=0.34, p=ns). Following smok­
ing, however, the group ingesting active marijuana showed a 
highly significant increase (Table 4; Period X Dosage, F=32.87, 
p<,0001) averaging 35 b/min. over base rate (Figure 2). No 
change in fast beat HR was evident for the group ingesting 
placebo marijuana.
Similar findings were obtained for average slow beat HRs 
(HRMINAVG, Table 5) of the two groups. In this case, the rate
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Table 2.
Means and Standard Deviations for Psychological and 
Physiological Variables Before and After Marijuana Smoking.
Active Placebo
Variable Pre Post Pre Post
BVRTCOR 6.60 5.50 7.00 6.30
(1.71)a (1.78) (1.70) (1.16)
BVRTERR 4.90 7.90 4.70 5.30
(2.42) (4.07) (2.98) (2.16)
STATEANX 34.30 38.20 33.60 28.50
(6.04) (15.19) (6.92) (5.50)
TRAITANX -- 33.80
(5.80)
--- 35.50
(8.38)
RATING — —  — 4.05
(1.01)
----- 1.95
(0.57)
TIMEJEST 135.20 162.30 118.00 119.00
(33.72) (40.77) (25.30) (35.26)
DRT_AVG 385.07 372.32 480.73 416.80
(118.59) (91.25) (215.28) (126.04)
DRTMISS 1.6 1.8 0.7 1.2
(1.02) (1.72) (0.64) (1.08)
CPA_AVG 17.48 10.80 19.15 21.05
(6.27) (4.90) (6.54) (10.99)
DPA_AVG 11.84 4.63 19.18 20.78
(3.15) (3.01) (6.97) (11.94)
HRMAXAVG 68.21 103.19 76.09 76.46
(12.79) (15.84) (13.62) (13.69)
HRMINAVG 59.45 98.81 66.67 67.21
(12.09) (17.89) (11.58) (13.14)
SYSBRPAVG 127.80 136.92 127.36 130.04
(12.49) (13.79) (12.57) (9.68)
DIABPAVG 94.40 99.90 94.26 94.96
(14.24) (12.51) (10.00) (9.42)
aStandard Deviation
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Table 3.
Multivariate Analysis of Variance on Five Psychological3 
and Six Physiological*3 Variables for Active and Placebo 
Marijuana Groups during Pre- and Post-Smoking. Periods.
F DF p(F)
MANOVA Test Criteria for Overall Dosage Effect
HotelTing-Lawley1s Trace = 4.336 3.15368 11/8 0.0572
Pillai's Trace = 0.81260441 3.15368 11/8 0.0572
Wilk's Criterion ™ 0.18739559
Roy’s Maximum Root Criterion «
4.33630498 First Canonical
Variable Upper Bound - 78.05349 1/18
MANOVA Test Criteria for Overall Period Effect
Hotelling-Lawley's Trace =
12.99568240
Pillai*s Trace = 0.9285439 
Wilk's Criterion = 0.07145061
Roy's Maximum Root Criterion =
12.99568240 First Canonical 
Variable Upper Bound -
9.45141
9.45141
11/8
11/8
233.02228 1/18
0.0025
0.0025
MANOVA Test Criteria for Period*Dosage Effect 
Hotelling-Lawley's Trace =
t :
Pillai*s Trace = 0.90561410
Wilk's Criterion = 0.09438590
Roy's Maximum Root Criterion = 
9.59480294 First Canonical 
Variable Upper Bound -
6.97804
6.97804
11/8
11/8
172.70645 1/18
0.0060
0.0060
aBVRTCOR, BVRTERR, STATEANX, TIME EST, DRT_AVG 
bHRMAXAVG, IIRMINAVG, CPA_AVG, DPA'AVG, SYRRPAVG, DIABPAVG
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Table 4.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Peak
Heart Rates of Active and Placebo Marijuana Groups
Source
Sum
Squares DF
Mean
Squares F P
Total 14095.73
Among Subjects 6337.40 19
Dosage (groups) 888.78 1 888.78 2.94 ns
Ss within groups 5448.62 18 302.70
Within Subjects 7758.33
Periods 3124.94 1 3124.94 34.31 0.0001
Period X Dosage 2993.76 1 2993.76 32.87 0.0001
Period X Ss
within groups 1639.63 18 91.09
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, Fast beat heart rates for active and placebo 
marijuana groups.
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Table 5.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Slow
Beat Heart Rates of Active and Placebo Marijuana Groups
Source
Sum
Squares DF
Mean
Squares F P
Total 16188.94 39
Among Subjects 7007.56 19
Dosage (groups) 1485.96 1 1485.96 4.84 <0.05
Ss within groups 5521.60 18 306.76
Within Subjects 9181.38 20
Periods 3980.03 1 3980.03 49.90 0.0001
Period X Dosage 3765.54 1 3765.54 47.21 0.0001
Period X Ss
within groups 1435.81 18 79.77
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for the active marijuana group changed even more dramatically 
(Period X Dosage, F=47.21, p<.0001) since a significant over­
all difference between groups (Dosage, F=4.84, p<.05) was 
also found in association with nonsignificant group differ­
ences during the pre-smoking period (Tukey's "a"=0.31, p=ns). 
Comparison of group means for slow beat HR, as presented in 
Figure 3, with Figure 2 suggests that most of the Slow beats 
dropped out following ingestion of active marijuana. These 
data support the initial hypothesis that HR increase is a 
significant physiological change consistently associated with 
ingestion of active marijuana.
Cerebral Pulse Amplitude. The data for this variable 
also support the initial hypothesis that one of the major 
cardiovascular changes occurring after active marijuana in­
gestion is a sharp decline (Figure 4) in the height of the 
anachrotic limb of the pulse pressure wave. The active mari­
juana group showed a significant decrease from base levels 
(Table 6; Period X Dosage, F=18, p<.0007) which averaged ap­
proximately 40% (Table 2). Although the two groups did not 
differ initially on this variable (Tukey's "a"=0.52, p=ns), 
the placebo group showed a slight but not significant tendency 
toward vasodilatation (increased CPA) while the active mari­
juana group demonstrated marked vasoconstriction after smok­
ing. Vasodilatation over time would be the normal expectation 
for Ss performing repetitive and relatively easy tasks in new 
surroundings as they became more accustomed to their duties
Figure
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3. Slow beat heart rates for active and placebo 
marijuana groups.
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Cerebral pulse amplitudes for active and placebo 
marijuana groups.
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Figure 5. Digital pulse amplitudes for active and placebo 
marijuana groups.
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Table 6.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Cerebral
Pulse Amplitudes of Active and Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 2639.03 39
Among Subjects 2217.64 19
Dosage (groups) 355.51 1 355.51 3.44 ns
Ss within groups 1862.13 18 103.45
Within Subjects 421.39 20
Periods 57.24 1 57.24 5.72 0.0265
Period X Dosage 183.83 1 183.83 18.36 0.0007
Period X Ss
within groups 180.27 18 10.01
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and environment.
Digital Pulse Amplitude. The data analysis (Table 7) 
for this variable is very similar to that for CPA. Again, ex­
perimental and placebo groups did not differ significantly on 
DPA__AVG during the pre-smoking period (Tukey's "a"<l, p=ns). 
After smoking, however, the active marijuana group showed sig­
nificant digital constriction (Period X Dosage, F=7.05, p<.02). 
This decrease from basal levels for the active marijuana group 
averaged more than 60% (Table 2) , while the placebo group 
showed no discernable change (Figure 5).
Blood Pressure. The ANOVAs for systolic (Table 8) and 
diastolic (Table 9) blood pressure indicate that there were no 
significant differences between the active and placebo mari­
juana groups on these respective variables prior to smoking. 
There was a slight increase (Figure 6) in systolic blood pres­
sure and a significant period effect (F=4.90, p<.05) for this 
variable; but a more conservative test between the means of the 
active marijuana group, which showed the most change, indicated 
no difference (Tukey's "a"=1.08, p=ns). The significant, and 
more sensitive, F statistic for period main effect probably 
occurred because of the tendency of both groups to show 
slightly increased blood pressures over time. The initial hy­
pothesis that blood pressure would not change following mari­
juana ingestion, despite other cardiovascular changes, is sup­
ported by these results.
Subjective Ratings. The two groups tended to rate the 
degree of marijuana intoxication very differently (Table 2)
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Table 7.
2 X 2  Analysis of Variance for Pre- and.Post-Smoking Digital
Pulse Amplitudes of Active and Placebo Marijuana Groups
Source
Sum
Squares DF
Mean
Squares F P
Total 3544,04 39
Among Subjects 2777,09 19
Dosage (groups) 1379.16 1 1379.16 17.76 <0.01
Ss within groups 1397.93 18 77.66
Within Subjects 766.95 20
Periods 78.75 1 78.75 2.87 0.1044
Period X Dosage 193.71 1 193.71 7.05 0.0154
Period X Ss
within groups 49 4.49 18 27.47
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Table 8.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Systolic
Blood Pressures of Active and Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 5968.93 39
Among Subjects 4239.69 19
Dosage (groups) 133.96 1 133.96 0.59 ns
Ss within groups 4105.73 18 228.10
Within Subjects 1729.24 20
Periods 348.10 1 348.10 4.90 0.0379
Period X Dosage 103.68 1 103.68 1.46 0.2410
Period X Ss
within groups 1277.46 18 70.97
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Table 9.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Diastolic
Blood Pressures of Active and Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 5151.43 39
Among Subjects 4199.51 19
Dosage (groups) 64.52 1 64.52 0.28 ns
Ss within groups 4134.99 18 229.72
Within Subjects 951.92 20
Periods 96.10 1 96.10 2.17 0.1552
Period X Dosage 57.60 1 57.60 1.30 0.2688
Period X Ss:
within groups 798.22 18 44.35
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Figure 6. Systolic and diastolic blood pressures for active
and placebo marijuana groups.
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on a five-point scale (l=not intoxicated; 5»very intoxi­
cated) . The group differences in this respect were very 
significant (Table 10; F=>29.51, pc.0001), with little over­
lap between the distributions (Figure 7). The modal rating 
for the active marijuana group was 5.0, the highest possible. 
This is relatively surprising since all S£ were experienced 
(but not chronic) users of marijuana, and the dosage level 
was only moderate. One possible conclusion might be that 
illegally obtained marijuana has a low percentage of THC. 
Another interpretation might be that the experimental pro­
cedure and/or past experience produced a positive response 
set or conditioned response in these &s. This latter in­
terpretation is even more probable in the case of placebo 
group members (Modal rating=2) who maintained that they felt 
at least slightly intoxicated, despite the fact that their 
marijuana was essentially inactive. Unsystematic observa­
tions made by E suggested that many of these S£ convinced 
themselves only with some effort that they had actually been 
intoxicated, even though all §£ were told that they would 
smoke "a marijuana cigarette". These group differences in 
ratings of the subjective experience were consistent with 
their physiological responses (or lack of response) to mari­
juana.
Time Perception. The time estimation task proved to be 
highly sensitive to marijuana ingestion (Table 11). Although 
active and placebo marijuana groups did not differ signifi­
cantly in their initial estimations (Tukey's "a"=1.10, p=ns)
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Table 10.
Analysis of Variance for Subjective Ratings of Active and 
Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 35.50 19
Among Subjects 35.50 19
Dosage (groups) 22.05 1 22.05 29.51 0.0001
Ss within groups 13.45 18 0.75
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Rating
Figure 7. Subjective ratings of degree of marijuana intoxi­
cation for active and placebo marijuana groups.
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Table 11.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Estima­
tions of a Two-Minute Interval of Active and Placebo Marijuana
Groups.
Source
Siam
Squares DF
Mean
Squares F P
Total 54967.39 39
Among Subjects 47375.88 19
Dosage (group) 9150.63 1 9150.63 4.31 ns
Ss within groups 38225.25 18 2123.63
Within Subjects 7591.51 20
Periods 1974.03 1 1974.03 9.08 0.0074
Period X Dosage 1703.03 1 1703.03 7.83 0.0115
Period X Ss
within groups 3914.45 18 217.47
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of the fcv;o-minute interval, the active marijuana group sig­
nificantly overestimated it (Period X Dosage, F=7.83, p<.02) 
after smoking. In contrast, the placebo group was quite ac­
curate (Figure 8) on both occasions. These findings support 
the hypothesis that marijuana ingestion distorts the subjec­
tive sense of time by accelerating subjective time in rela­
tion to objective time.
Visual Retention. None of the expected losses in per­
formance of a short-term visual memory task (BVRT) were ob­
served (Table 12). The only significant finding regarding 
the number of designs correctly reproduced was that members 
of both groups deteriorated somewhat in their performances 
over time (Period main effect, F=6.78, p<.02). This overall 
change (Figure 9) is likely to be related to some combination 
of decreasing motivation and fatigue during the lengthy ex­
periment. The hypothesis that marijuana ingestion deleteri- 
ously affects short-term visual memory was not supported by 
the data.
The greater sensitivity (Table 13) of the error scoring 
of the BVRT reproductions to the experimental manipulations 
may have interpretive importance. Although the active mari­
juana group's correct BVRT reproductions did not change sig­
nificantly from pre- to post-smoking administrations, the 
number of scoreable errors (Figure 10) on those items which 
were incorrect increased significantly during the latter ad­
ministration (Period X Dosage, F=14.40, p<.05). The placebo 
group, however, did not change significantly (Tukey's "a"=1.07,
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Figure 8. Estimations of two-minute time interval for active 
and placebo marijuana groups.
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Table 12.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Scores
of the BVRT (Number Correct) of Active and Placebo Marijuana
Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 108.70 39
Among Subjects 78.70 19
Dosage (group) 3.60 1 3.60 0.91 ns
Ss within groups 75.10 18 3.97
Within Subjects 30.00 20
Periods 8.10 1 8.10 6.78 0.0171
Period X Dosage 0.40 1 0.40 0.33 0.5762
Period X S£
within groups 21.50 18 1.19
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Figure 9. Benton Visual Retention Test performances (number
correct) of active and placebo marijuana groups.
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Table 13.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Scores
of the BVRT (Number of Errors) of Active and Placebo Marijuana
Groups.
Source
Siam
Squares DF
Mean
Squares F P
Total 390.40 39
Among Subjects 287.40 19
Dosage (group) 19.60 1 19.60 1.32 ns
Ss within groups 267.80 18 14.88
Within Subjects 103.00 20
Periods 32.40 1 32.40 10.38 0.0049
Period X Dosage 14.40 1 14.40 4.61 0.0434
Period X Sis
within groups 56.20 18 3.12
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Figure 10. Benton Visual Retention Test performances 
(number errors) of active and placebo 
marijuana groups.
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p=ns) on this variable. Ss who had ingested active marijuana 
frequently appeared to confabulate and/or perseverate on 
failed items/ often drawing or adding figures which in no 
respect resembled the forgotten design.
Anxiety. Situational anxiety was not significantly af­
fected by the experimental manipulations (Table 14). Al­
though changes in state anxiety were nonsignificant for both 
groups, the direction of change (Figure 11) was contradictory 
to the hypothesis that the active marijuana group would show 
a significant decrease in situational anxiety. Instead, a 
slight increase in anxiety is indicated for the group as a 
whole, while a slight decrease is indicated for the placebo 
group. These trends may be the result of some interactional 
effect of marijuana's physiological consequences with situa­
tional factors, since there evidently were no real differ­
ences between the groups in terms of anxiety-proneness as 
measured by the trait-anxiety scale (Table 15). The un­
characteristic increase in variability of the active mari­
juana group in state-anxiety scores obtained at the post- 
smoking administration (Table 2) is principally the result 
of one subject's response. During the DRT procedure follow­
ing his ingestion of marijuana, he became quite aware of his 
tachycardia and very concerned that one of his professors 
at the medical school might, by chance, see him participating 
in the experiment. This concern evidently developed after 
a co-investigator (a member of the medical school faculty) 
entered the laboratory while the S was smoking the marijuana
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Table 14.
2 X 2  Analysis of Variance for Pre- and Post-Smoking State
Anxiety Scores of Active and Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 3587.79 39
Among Subjects 2175.28 19
Dosage (groups) 275.63 1 275.63 2.61 ns
Ss within groups 1899.65 18 105.54
Within Subjects 1412.51 20
Periods 4.23 1 4.23 0.06 ns
Period X Dosage 198.03 1 198.03 2.95 0.0999
Period X Sis
within groups 1209.25 18 67.18
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Figure 11. State anxiety scores for active and placebo 
marijuana groups
94
Table 15.
Analysis of Variance for Trait Anxiety Scores of Active and 
Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F p
Total 1060.55 19
Among Subjects 1060.55 19
Dosage (groups) 14.45 1 14.45 0.25 ns
Ss within groups 1046.10 18 58.12
cigarette. The S was assured at the time that this indivi­
dual had a major involvement in the study, that he only 
desired to observe the procedure., and that no one else was 
allowed to enter the laboratory. These assurances evidently 
had no effect since the S's pre-sraoking state-anxiety score 
was 32 and the post-smoking score was 74. Four other S£ 
in the active marijuana group registered small to moderate 
increases on this variable, while the remaining five experi­
mental Ss reported small to moderate decreases. All Ss 
registering increased anxiety levels after smoking rated 
the degree of intoxication as either 4 (n=l) or 5 (n=4) on 
the five-point rating scale, while four of the five Sis who 
registered a decrease in anxiety rated the degree of intoxi­
cation as 3 or less.
Reaction Time. The DRT procedure, either as a measure 
of psychomotor speed (DRT_AVG; Table 16) or attentional 
fluctuation (DRTMISS; Table 17), did not appear to be sensi­
tive to the experimental manipulations. The contentions that 
marijuana adversely effects choice reaction time and causes 
attentional fluctuations were not supported by the data. 
Figure 12 suggests that the placebo group initially achieved 
somewhat slower average RTs than did the active marijuana 
group. The placebo group tended to improve somewhat over 
time, presumably as the result of practice, while the active 
group showed no change from their relatively fast RTs during 
the pre-smoking period.
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Table 16.
2 X 2  Analysis of Variance for Pre- and Post-Smoking Disjunc
tive Reaction Times of Active and Placebo Marijuana Groups.
Source
Sum
Squares DF
Mean
Squares F P
Total 827243.71 39
Among Subjects 677580.61 19
Dosage (groups) 44983.56 1 44983.56 1.28 ns
Ss within groups 632597.05 18 35144.28
Within Subjects 149663.10 20
Periods 12489.90 1 12489.90 1.74 ns
Period X Dosage 8174.64 1 8174.64 1.14 ns
Period X Ss
within groups 128998.56 18 7166.59
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Table 17.
Analysis of Variance for Missed Reaction Time Trials of 
Active and Placebo Marijuana Groups.
Source
Sum
Squares DP
Mean
Squares F p
Total 43.00 19
Among Subjects 43.00 19
Dosage (groups) 1.80 1 1.80 0.79 ns
Ss within groups 41.20 18 2.29
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Figure 12. Disjunctive reaction times for active and placebo 
marijuana groups.
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Discussion
The present study was designed to assess the effects of 
smoking marijuana on a multivariate system of psychological 
and physiological variables. These two classes of variables 
were simultaneously observed in order that certain hypothe­
sized physiological relationships consequent to marijuana in­
gestion could be related to concomitant changes in the psy­
chological functioning of THC-intoxicated subjects. A 
repeated-measures design was utilized to enable each S to 
serve as his own control, thereby limiting the influence of 
initial biological differences which would otherwise consti- 
tude a major confounding factor limiting the interpretabil- 
ity of results. The use of a baseline measurement period 
prior to smoking also maximized the possibilities for physio­
logical and psychological stabilization, as each S became 
familiarized with the experimental setting and tasks. Further 
control was obtained by comparing a placebo marijuana group 
and an active marijuana grpup in double-blind fashion. This 
methodology enabled some control of possible placebo effects 
and artifactual effects of the experimental situation (such 
as suggestion, conditioned expectancy responses, situational 
demands and the like), thereby allowing a more accurate deter­
mination of the psychophysiological consequences of marijuana 
intoxication which were directly related to the active ingredi­
ent alone.
A multivariate analysis of the eleven-variable hyperspace
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indicated that the vector represented by scores on five psy­
chological and six physiological variables during the post­
smoking period was significantly different from the vector 
obtained from baseline data for the same variable system.
This difference represented change over time, but the direc­
tion and amount of change was the result of a unique combina­
tion or combinations of dosage and time of measurement. In­
spection of the ANOVAs suggested that most of this change was 
attributable to the active marijuana group during the post­
smoking period. Two of the five psychological variables and 
four of the six physiological variables appear to be primary 
sources of this variance. Since the physiological parameters 
are most central to the formulation of this study, the find­
ings relevant to each of the cardiovascular variables will be 
discussed below, and psychological considerations will appear 
at a later point to allow a more amenable integration of the 
findings.
Physiological Findings
In accordance with initial hypotheses, significant in­
creases in heart rate and decreases in cerebral and digital 
pulse amplitudes were observed following ingestion of active 
marijuana, while blood pressure showed no change from base­
line levels. No significant changes on any of the cardio­
vascular parameters were observed following ingestion of 
placebo marijuana. The finding of this investigation that 
neither systolic nor diastolic blood pressure changed during 
marijuana intoxication is in agreement with results reported
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by Williams and associates (1946), Isbell and associates 
(1967) and Isbell and Jasinski (1969). Dosages utilized in 
the latter two studies were much higher than in the present 
investigation. Waskow and associates (1970) have reported 
small decreases in blood pressure, and slight increases were 
reported by Johnson and Domino (1971); but these appear to be 
statistically insignificant and possibly more related to 
methodological considerations since no placebo group was used 
in either study. Dixon's (1899) finding of an initial de­
crease followed by a permanent increase in blood pressure is 
not easily reconciled with those of the present investigation. 
Dixon, however, did not report dosage level, measurement pro­
cedures, nor a statistical analysis of raw data. Furthermore, 
his experimental group was not compared to any control group.
The cardiovascular syndrome observed after ingestion of 
active marijuana appears consistent with Efron's (1970) ortho­
static hypotension hypothesis and more so with Shmavonian's 
(1971) suggestion that THC ingestion may produce mild, tran­
sient, cerebral ischemia.
The concept of cerebral ischemia implies either a chronic 
or acute shortage in the cerebral blood supply, and conse­
quently, inadequate perfusion of some or all of the various 
brain-structures. This syndrome may result from a rapid 
postural change (as is the case in orthostatic hypotension) 
which produces arterial insufficiency through venous pooling 
in lower extremities. There are, however, a host of other 
etiologies having similar effects, such as occlusion or
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stenosis of any segment of the cerebral arterial tree; 
arterio-venous shunting; vasoconstriction; heart block and 
mitral insufficiency.
One issue which is of crucial importance to the physio­
logical implications of this investigation concerns the: mea­
surement of the cerebral blood supply. The photoelectric 
plethysmograph used in this study is an indirect, but re­
liable method for detecting change in tissue density prin­
cipally because of variation in its blood content (Shmavonian, 
1959; Wallace and Wallace, 1968). The amplitude (anachrotic 
limb) of the pulse pressure waveform generated by the plethys­
mograph has been demonstrated to provide a reliable and sim­
ple indicator of variations in blood supply which correlate 
highly with direct measures of flow (Hadjiev, 1968). In view 
of these measurement characteristics of the plethysmograph 
and the hemodynamic relationships presented earlier (Intro­
duction, pp. 39-40), it can be reasoned that a significant 
decrement in pulse amplitude which is not accompanied by a 
compensatory increase in blood pressure is indicative of de­
creased blood supply to a given area.
Assuming the validity of the equation P=BPa/RL, that is, 
perfusion equals mean arterial blood pressure divided by local 
resistance, then the findings of the present study are suppor­
tive of the notion that the ingestion of marijuana produces 
transient cerebral ischemia. Subjects ingesting active mari­
juana showed an average decrement of approximately 40% in 
cerebral pulse amplitude without significant changes in either
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systolic or diastolic blood pressure. Some portion of the 
observed decline in blood supply may have resulted from de­
creased cardiac output, since stroke volume begins to show 
some decline with tachycardia in the range of 80 to 100 
beats/min. in normally healthy human subjects (Schade and 
McMenemy, 1963). The average HR increase for the active 
marijuana group from a pre-smoking level of 68 beats/min. 
to a post-smoking level of 103 beats/min. supports this hy­
pothesis, given the assumption of the relationship of stroke 
volume to heart rate. Another interpretation of these find­
ings is that the decline in cerebral pulse amplitude could 
have been the result of vasoconstriction, since arteriole 
diameter and elasticity are responsible for most of the re­
sistance in the hemodynamic system. This investigation did 
not provide data which would aid in interpreting the rela­
tive contributions of vasoconstriction and cardiac output 
to the observed decline in average cerebral pulse amplitude. 
However, several unsystematic observations made during this 
study suggest that the post-smoking decline in cerebral pulse 
amplitude preceded heart rate accelerations by several sec­
onds. Further systematic study of these temporal relation­
ships is needed to determine if the marijuana-induced tachy­
cardia is a principal response or if it represents a homeo­
static compensatory mechanism secondary to vascular activity.
A second issue having considerable importance with re­
gard to present findings, concerns the degree of correspon­
dence between surface plethvsmographic recordings and deeper
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vascular activity. For the purpose of monitoring cerebral 
circulation in this investigation, the plethysmograph was 
placed on the forehead, approximately 2 centimeters to the 
right of the midline and 1.5 centimeters above the eyebrow.
This site is served by the supraoptic branch of the ophthal­
mic artery, a major division of the middle cerebral artery. 
Accuracy of this placement can be checked with extrinsic 
compression of the supraoptic as it exits the supraorbital 
foramen. If the placement of the plethysmograph is accurate, 
compression of the artery will produce a sharp decrement in 
the pulse amplitude. In addition to the anatomical evidence 
for the validity of this method as an indicator of deep cere­
bral blood flow, considerabel physiological evidence has been 
reported by Wallace and Wallace (1968) and Omura and Lee 
(1971). Based on the clinical and laboratory work of these 
investigators, the supraoptic placement yields reliable in­
formation as to the status of the internal carotid and com­
mon carotid arteries, since both natural constriction and 
extrinsic compression of the latter vessels produces a de­
cline in pulse amplitude at the recording site proportional 
to the degree of occlusion. Since the middle cerebral, which 
supplies blood to the anterior portions of the cortex as well 
as some of the deeper structures, is the major anatomical 
link between the supraoptic and the internal carotid, the 
forehead placement used in this study was assumed to reflect 
anterior cortical blood supply.
Digital pulse amplitude was utilized in this investigation
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as an indicator of peripheral blood supply in order to im­
prove estimations of the overall circulatory response to 
marijuana. A decline in average digital pulse amplitude of 
approximately 60% of the baseline value was observed for sub­
jects ingesting active marijuana, while those who smoked the 
placebo dosage showed a slight average increase on this mea­
sure. This latter finding indicates an absence of any drug 
effect for the placebo group, and is indicative of nothing 
more than relaxation over time as the novelty of the labora­
tory environment declined. The findings with regard to the 
active marijuana group, however, suggest that the peripheral 
circulation was compromised in addition to the reduction in 
cerebral circulation discussed previously. Since the hemo­
dynamic system is a closed system, these findings suggest 
that the blood which is apparently diverted from cephalic and 
upper peripheral areas is pooling elsewhere in the body. The 
most likely sites of pooling would be the liver, kidney, gut 
and lower extremities. If this is the case, these findings 
may provide some explanation of the frequently reported symp­
toms of hunger, fatigue and desire for inactivity associated 
with marijuana intoxication.
Both fast beat and slow beat measures of heart rate were 
recorded in this investigation since the heart rate receives 
dual ennervation from both adrenergic and cholinergic fibers 
of the autonomic nervous system. Heart rate acceleration 
may result from either the activation of adrenergic receptors 
or decreased cholinergic activity (Hurst and Logue, 1970).
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In the latter case, tachycardia is principally the result of 
diminished slow beat activity as the diminishing of choliner­
gic activity no longer provides a damping effect on the car­
diac autonomic balance. Following ingestion of active mari­
juana, a significant and prolonged tachycardia was observed in 
both fast and slow beat measures. While the fast beat measure 
showed an increase from the baseline level of 6 8 beats/min. to 
a post-smoking average of 103 beats/min., slow beat activity 
increased from a baseline of 59 beats/min. to 99 beats/min.
The post-smoking slow beat average is nearly identical to the 
fast beat average, and inspection of the polygraphic records 
indicated that the normal respiratory sinus arrythmia was ab­
sent during most of the post-smoking period. These findings 
suggest the possible implication of cholinergic blocking in 
the physiological response to marijuana. The findings of Drew 
and associates (1972) that propranolol, a beat-adrenergic 
blocking agent, prevents the marijuana tachycardia is not con­
clusive evidence that adrenergic receptors are primarily re­
sponsible for the heart rate a c c e l e r a t i o n  associated with mari­
juana intoxication. In view of the p r e s e n t  s t u d y ,  Drew's (1972) 
finding that intellectual performance, deteriorated despite 
propranolol blocking of the marijuana tachycardia suggests 
that propranolol may not affect vasoconstrictor mechanisms 
involving alpha-adrenergic receptors (Kelman, 1971). Further 
study of the relative effects of alpha-adrenergic and beta- 
adrenergic blocking agents is needed to provide additional 
evidence as to a mechanism of action for marijuana.
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Psychological Findings
The most salient behavioral effect of marijuana observed 
in this study was the significant distortion in the perception 
of time. Subjects who smoked active marijuana consistently 
overestimated a two-minute time interval by an average of 42 
seconds, while the averaged estimations of subjects who smoked 
placebo marijuana were within two seconds of the actual inter­
val. This overestimation of the passage of time is consis­
tent with the findings reported by Melges and associates (1970, 
1971), Weil and associates (1968), Jones and Stone (1970), 
Hollister and associates (1970) and Clark and associates (1970). 
This phenomenon could be consistent with "biological clock" 
theories (Wallace and Rabin, 1960) which suggest that biologi­
cal activity within the organism provides clues regarding the 
passage of time, and therefore, that acceleration of natural 
biological rhythms would produce an unduly accelerated per­
ception of time passage. Decrements in short-term memory for 
sequences of external or internal (i.e. thought sequences) 
events might also serve to accelerate the subjective percep­
tion of time. Considerable evidence for a relationship be­
tween the acceptance or rejection of environmental cues and 
changes in heart rate has been provided by the Laceys (Lacey 
and Lacey, 1970). They have demonstrated that cardiac ac­
celeration is consistently associated with decreased attention 
to external, environmental cues and increased attention to 
internal cognitive processes, while cardiac deceleration is 
strongly associated with acceptance of environmental stimulation.
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The relaxation of concern over external events and the pre­
occupation with internal thought processes are symptoms re­
ported with great frequency as concomitants of marijuana in­
toxication and have been documented in the survey studies 
cited earlier. The focusing of attention on more active 
thought processes at the expense of attending to more re­
liable, external cues of the passage of time would accelerate 
the subjective sense of time during marijuana intoxication.
The Benton Visual Retention Test, even with the modifi­
cations employed to increase the difficulty of the task in 
the present study, proved to be a relatively poor discrimina­
tor of decrements in short-term visual recall during mari­
juana intoxication. The number of designs correctly repro­
duced by the active marijuana group did not differ signifi­
cantly from that of the placebo group, although the former 
group made significantly more errors on missed designs than 
did the latter. The apparent discrepancy of results based 
on correct and error scorings of t h i s  t a s k  is probably the 
result of psychometric d i f f e r e n c e s  i n  t h e  d e r i v a t i o n  of the 
two systems, the error scoring b e i n g  t h e  m o r e  sensitive of 
the two because of its greater r a n g e .  The findings based on 
the error scoring of this task o f f e r  t e n t a t i v e  support for 
the initial hypothesis that m a r i j u a n a  intoxication adversely 
affects short-term visual recall, and they are consistent 
with other reports of deficits observed on short-term memory 
tasks during marijuana intoxication (e.g. Halpern, 1944; 
Tinklenberg and associates, 1970? Dornbush and associates,
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1971; Abel, 1971a, 1971b). The types of errors made by the 
active marijuana group during the post-smoking administra­
tion were predominantly classifiable as major perseverations 
(repeated reproductions of an inaccurate figure) and con­
fabulations, while errors from the pre-smoking administra­
tion for this group and both administrations of the placebo 
group were most often simple omissions, perseverations and 
minor rotations of the designs. These findings suggest that 
decrements in intellectual performance during marijuana in­
toxication, at least at moderate dosage levels, are fairly 
subtle and may only be observed in marijuana-experienced sub­
jects with psychometrically-sensitive instruments.
The present investigation was unable to demonstrate sig­
nificant change in reaction time (DRT_AVG) in relation to 
marijuana intoxication. These findings for the RT variable 
are consistent with those reported by Dornbush and associates 
(1971), Hollister and Gillespie (1970) and Clark and asoci- 
ates (1970). Since the dosages utilised in these four studies 
range from very low (25 yg/kg) to v e r y  high ( 2 2 5  y g / k g ) ,  it 
seems improbable that marijuana has a n y  significant effect on 
the functioning of lower motor c e n t e r s .  H o w e v e r ,  two meth­
odological difficulties in this i n v e s t i g a t i o n  suggest a need 
for replication of the DRT paradigm. First, although sub­
jects were assigned to groups with a randomized, double­
blind procedure, the data indicate that the active and placebo 
groups differed significantly in baseline levels of DRT. The 
post-smoking improvement of the active marijuana group may be
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viewed as an instance of regression toward a mean, a change 
which would be unrelated to marijuana ingestion. A replica­
tion of this design where the two groups were initially 
equated on the DRT performance would provide a more accurate 
examination of the effects of marijuana on this variable. 
Second, the use of a fixed-foreperiod (4 seconds) DRT para­
digm in this investigation may have allowed subjects to de­
velop expectations as to the occurrence of the imperative 
stimulus. The use of a variable-interval foreperiod in fu­
ture replications should overcome this difficulty.
Although Hollister and Gillespie (1970) and Clark and 
associates (1970) have reported significant variability in 
attentional level (as indicated by missed RT trials) follow­
ing marijuana ingestion, these findings were not supported 
in the present investigation. This discrepancy may be the 
result of methodological differences and differences in dos­
age levels (dosages in the former studies ranged over four 
times the amount used here). The u s e  o f  a  warning stimulus 
and a fixed foreperiod in this D R T  p a r a d i g m  p r o b a b l y  enhanced 
the degree of voluntary control over level of attention. The 
voluntary aspects of the a t t e n t i o n a l  p r o c e s s  during the 
marijuana-intoxicated state h a v e  b e e n  l i n k e d  to situational 
demand characteristics by Grinspoon (1971) , Tart (1971) and 
Isbell and associates (1967).
The observation that situationally-determined anxiety 
does not consistently change during marijuana intoxication 
does not depreciate the use of this parameter in future
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investigations, since it appears to be highly sensitive to 
situational and methodological characteristics of the experi­
mental environment. Anxiety level may also be related to 
previous experience with marijuana, although this question 
cannot be considered within the context of the present study 
since only subjects having a relatively narrow range of ex­
perience were used.
Subjective appraisal of level of intoxication appears to 
correspond very closely with dosage level. The modal rating 
of two for the placebo group on the five-point rating scale 
is surprising, since the placebo cigarettes contained no ac­
tive THC. This rating probably reflects situational demand 
characteristics, since all subjects were informed that they 
would smoke a marijuana cigarette, and no mention was made 
that it might be a placebo. The extreme ratings of level of 
intoxication made by the active marijuana group despite the 
moderate dosage level may indicate that illegally obtained 
marijuana is typically low-quality material. C u e  subject re­
ported that the only time he had been s o  a c u t e l y  i n t o x i c a t e d  
was with marijuana stolen from the NIMH farm.
Within the active marijuana group, subjective ratings of 
intoxication level also seemed to correspond to reports of 
change in anxiety level after smoking. Those subjects report­
ing the highest levels of intoxication a l s o  fended to show 
increased levels of anxiety, while those who rated their de­
gree of intoxication at more moderate levels tended to report 
decreased anxiety. This finding corresponds to the views of
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Schacter and Singer (1962) who emphasize the importance of 
the cognitive interpretation of physiological arousal to the 
quality of the associated emotional state.
Neuropsychological Imp1ications
The neocortical structures most susceptible to decreases 
in blood supply appear to be the anterior frontal and tem­
poral lobes, the inferior parietal lobule and the area of the 
angular gyrus (Ruch and Fulton, 196 0; Hurst and Logue, 1970; 
Morgan, 1965; Schade and McMenemy, 1963), since they are the 
most poorly vascularized areas of the brain. Mild cerebral 
insufficiency has been shown to adversely affect higher- 
order psychological and neurological functions (Schade and 
McMenemy, 1963) which are typically associated with these in­
tegrative areas (Luria, 1966). Interestingly, Mclsaac's in­
vestigation of the distribution of marijuana in the monkey 
brain (Mclsaac and associates, 1971) has implicated neocor­
tical structures, particularly the prefrontal region, as pri­
mary sites of radioactivity shortly after intravenous injection 
of carbon-labelled THC.
Since these neocortical structures have been assigned a 
major role in recent memory functions (Luria, 1966), the 
present finding of deficits in both blood supply to this area 
and performance on a short-term visual memory task during 
marijuana intoxication is consistent with the inference that 
the functional integrity of poorly vascularized neocortical 
structures is compromised by marijuana ingestion. Subcortical 
structures, however, may also be implicated as sites of action
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for this drug. For example, lesions of the medial thalamus, 
mammilary bodies and especially the anterior thalamus have 
been related to a loss of the sense of time (Morgan, 1965),
The confabulation, short-term memory loss, confusion and apa­
thy which typify the Wernicke-Korsakov syndrome also char­
acterize acute marijuana intoxication. The Mclsaac study 
has also implicated several subcortical structures, par­
ticularly the caudate nucleus (which has a high metabolic 
rate and has been implicated in hunger, as has the prefrontal 
cortex and the hypothalamus), lateral geniculate nucleus and 
several structures in Papaz' circuit.
The alterations of brain-behavior relationships during 
marijuana intoxication merit further investigation employing 
comprehensive neuropsychological, physiological, pharmacologi­
cal and psychophysiological techniques if a more precise un­
derstanding of marijuana's effects on the functional integrity 
of the central nervous system is to be obtained. In view of 
the possible harmful (particularly in relation to cardiovascu­
lar disorders) and therapeutic effects which may derive from 
the widespread and uninformed use of marijuana in this 
society, additional scrutiny within the objective framework 
of a scientific setting would be both relevant and timely.
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Marijuana Usage Questionnaire 
I, Demographic Information
Age  Race: white____ Mexican-American____
Sex  black____ other, specify_____________
Amer. Indian____
Approximate Grade Point Average (A=4.0)_____
Class standing: Freshman____ Sophomore____
Junior  Senior  Graduate____
Semester in college (circle one) 1 2 3 4 5 6 7 8 9  more
Father's occupation_____________________________________
Father's education grade school, grade completed_____
 high school, grade completed_____
 college, years completed Degree____
Circle yes or no:
yes no I do/did smoke tobacco cigarettes.
yes no I have/have had emotional, mental or behavioral 
problems which at one time or another have led 
to my considering or actually seeking counsel­
ing, therapy, or consultation with my physician, 
minister, priest, school counseling center or 
other professional person/agency.
yes no I have/have had significant physical or cardio­
vascular problems (such as polio, high or low 
blood pressure, anemia, epilepsy, heart murmur, 
diabetes, fainting, asthma, etc.). If yes, 
s p e c i f y ________________________________________
yes no I am presently taking medication for something 
other than a cold or flu. If yes, specify____
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II. Marijuana Usage
I presently use marijuana  never
 have tried it once or
twice
about once a month
about once a week 
more than twice a week
I have used marijuana, more or less regularly at the 
frequency checked above for
never
 less than one week
 less than one month
 less than 6 months
 6 months or more
III. Marijuana Experiences
I have found the effect of marijuana to be
 generally pleasant
 occasionally unpleasant
 frequently unpleasant
CHECK AS MANY OF THE FOLLOWING AS APPLY TO YOU
I have had one or more bad experiences using marijuana 
which were so frightening, so depressing or so un­
pleasant in some way that I would not want to repeat 
the experience even though I am capable of handling 
such bad experiences by myself or with my friends,
I have seen or heard things while stoned that I knew 
were entirely the result of my imagination.
  I have had unpleasant physical sensations while stoned
on marijuana.
On one or more occasions, I have become worried about 
"losing control" while using marijuana.
  I sometimes use marijuana when I am alone.
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I presently use, or have used marijuana at the same time 
during which one or more of the following drugs have 
been in my system
  amphetamine (speed)
LSD
non-prescribed barbiturates or
sedatives
psilocybin
STP, DOM, or DMT
alcohol
heroin or methadone
 other psychedelics, sniffed, smoked
or eaten, specify___________________
  other prescription medications
specify_____________________________
  I have used one or more drugs covered in the above
categories, but not at the same time as marijuana. 
Specify__________________________________________________
Based on my own personal experience only, the following is 
a list of marijuana effects which would improve my marijuana 
"high" if they were not present:
1.___________________________________
2 .____________________________________
3  . _________________________________________________________
4.
5.
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  I think that more scientific research on marijuana is
needed.
My knowledge of scientific research on marijuana is as 
follows:
none
 have heard friends and users talk about scientific
research on marijuana
 have heard lectures in which marijuana research
was discussed, mentioned or presented
 have read books, magazines or scientific journals
which discussed or presented research on marijuana
 have participated in a scientific study on
marijuana
I would volunteer to participate in a scientific study of the 
psychological and physiological effects of marijuana smoking 
which would require a maximum of 5 hours of my time on one 
afternoon:
Yes  no  need more information____
If answer to the above question was yes, I can be contacted 
at:
Telephone Number First Name only
I can usually be reached at this number at (time)_____________
In my opinion most of the research on marijuana up to the 
present time has probably had the following outcome with 
regard to marijuana usage:
favorable unfavorable
not clearly favorable or 
unfavorable
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